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The mammalian central nervous system (CNS) contains billions of neurons
each receiving thousands of synaptic inputs. Synapses are specified in part
through the precise localization of synaptic proteins, yet it has not previously
been possible to analyze the protein content of an individual class of
synapses. In order to achieve this, we have used the BAC (bacterial artificial
chromosome) transgenic approach to target particular neurons for expression
of

a

given

neurotransmitter

receptor

fused

to

an

affinity

tag.

Immunohistochemistry of fixed brain tissue confirmed the correct
localization of each synaptic fusion protein to the appropriate cell type and
morphological structure. In order to isolate the synaptic proteins of interest,
we developed a novel method, in which a classically purified crude
synaptosome fraction was subject to size exclusion chromatography to
enrich for synaptic protein complexes. The tagged synaptic protein
complexes were then purified by immobilization with antibody-coated
magnetic beads and the eluate analyzed by mass spectrometry.

This novel method was used to profile proteins at two classes of
synapses. First, we purified the parallel fiber to Purkinje cell synapse of the
cerebellum.

We identified ~60 post-synaptic proteins, including those

involved in phospholipid metabolism and signaling, which are major
unrecognized components of this synapse type.

Second, we analyzed

inhibitory synapses of layer V pyramidal cells of the cerebral cortex, thereby
accomplishing the first successful in vivo purification of an inhibitory
synaptic protein complex. We identified ~12 proteins, many of which have
been implicated in inhibitory synapse structure and function in vitro, such as
the scaffolding protein, gephyrin. The result of this work provides a novel
approach for detailed investigations of the biochemical complexity of CNS
synapse types.
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CHAPTER I. INTRODUCTION
Synaptic structure
Information

processing

in

the

nervous

system

depends

on

the

electrophysiological and pharmacological properties of neurons and
neuronal elements. The release of neuroactive substances at a specialized
locus, the synapse, is the most common method by which neurons influence
one another. Neuronal activity at the synapse is classified by whether it
increases (excitatory) or decreases (inhibitory) the membrane potential of the
postsynaptic neuron. Synapses can be broadly divided into two distinct
classes: Type I (asymmetric) or Type II (symmetric), based on the relative
density of material on the pre- and postsynaptic neuronal membranes (Figure
1). Although there are many exceptions, neurons making type I synapses
typically have excitatory actions, while those making type II synapses have
inhibitory actions [15]. All neurons receive both excitatory and inhibitory
inputs, however, the postsynaptic location of these inputs is distinct.
Broadly speaking, excitatory synapses are made on dendritic shafts, usually
on dendritic spines, and not on somata or axons, while inhibitory synapses
are generally found on proximal dendritic shafts, somta and axon initial
segments [13, 17].
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Figure 1. Gray’s Type I and Type II synapses. (A) Type I (asymmetric;
excitatory). The axons contain predominantly spherical vesicles and form
synapses that are distinguished by a thickened, postsynaptic density. Scale
bar = 0.22 µm. (B) Type II (symmetric; inhibitory) Axons contain clusters of
vesicles that are predominantly flattened or elongated in their appearance.
The pre-and postsynaptic membranes are more parallel than the surrounding
non-synaptic membrane, and the synapse does not contain a prominent
postsynaptic density [12]. Scale bar = 0.25 µm.

A large proportion of excitatory neurotransmission is due to presynaptic release of the neurotransmitter glutamate, an excitatory amino acid.
Glutamate receptor (GluR) channels function in fast excitatory synaptic
transmission, synaptic plasticity, and higher brain functions such as learning
and memory [18-20]. Based on pharmacological and electrophysiological
properties, GluR receptors have been classified into three major subtypes: αamino-3-hydroxy-5-methyl-4-isozaxole propionic acid (AMPA), kainate,
and N-methyl-D-aspartate (NMDA) receptors [15]. All these receptors are
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components of tightly associated, multiprotein complexes. Components of
these complexes regulate the synaptic targeting or removal from synaptic
sites, local expression, signal transduction, and clustering of receptors [22].
Fast inhibitory neurotransmission is mediated by two different
neurotransmitters in the nervous system: γ-aminobutyric acid (GABA) and
glycine. GABA is the most abundant inhibitory neurotransmitter of the
nervous system. Neurons that release this neurotransmitter form a diverse
group that includes interneurons throughout the central nervous system
(CNS).

Inhibitory neurotransmission plays a key role in controlling

neuronal activity. Accordingly, modulating the function of GABA receptors
results in significant consequences for neuronal excitation [15]. In addition,
these receptors are important for neural development and function, as
demonstrated by gene deletion and mutation experiments [23].

GABA

receptors are important therapeutic targets for a range of sedative, anxiolytic,
and hypnotic agents, including a major class of anxiolytic molecules, the
benzodiazepines. They are also involved in a number of CNS diseases,
including sleep disturbances, anxiety, premenstrual syndrome, alcoholism,
muscle spasms, Alzheimer's disease, chronic pain, schizophrenia, bipolar
affective disorders, and epilepsy [24]. Given the importance of GABA
receptors in the central nervous system it is noteworthy that their interacting
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synaptic proteins have been exceedingly difficult to purify and identify. The
molecular specialization at inhibitory synapses is an emerging field, and
further work is likely to reveal novel therapeutics for treating a host of
neurological and psychiatric conditions.

Study of synaptic proteins
Neurons interact with one another at the synapse, a specialized contact
between the pre- and postsynaptic neuronal membranes. The postsynaptic
membrane of excitatory synapses contains a highly organized structure
called the postsynaptic density (PSD), which is composed of glutamate
receptors,

associated

signaling

proteins,

scaffolding

proteins,

and

cytoskeletal elements [25]. AMPA receptor-interacting proteins are located
in the PSD, and analysis of this specialized structure is crucial to the study of
synaptic specificity. In many neurons in the mammalian brain, including
pyramidal neurons of the cerebral cortex and hippocampus and Purkinje
cells of the cerebellum, the PSD is located on membrane protrusions called
dendritic spines. The dimensions of the spine head are highly correlated
with the size of the PSD and associated active zone, as well as synaptic
strength [26].

Unlike excitatory synapses, inhibitory synapses lack a

defined PSD and contacts are made on the dendritic shaft, the axon initial

4

segment, or soma [15].

Biochemical analysis of excitatory synaptic

elements benefits from the ease of enrichment of PSD through several steps
of centrifugation [27], while inhibitory synaptic complexes are not easily
enriched [28, 29]. Because of this difference in synaptic structure the study
of synaptic proteins has been largely biased in favor of excitatory synapses.
Classical PSD purification from the mammalian brain begins with
homogenization followed by differential centrifugation and sucrose or
Percoll

gradient

sedimentation

to

obtain

synaptosomes

[27,

30].

Synaptosomes are formed from the phospholipid layer of the cell membrane
and synaptic proteins and they also contain the presynaptic machinery
necessary for the uptake, storage, and release of neurotransmitters [27, 30].
Following synaptosome enrichment, the PSD is purified through extraction
with nonionic detergents, such as Triton X-100 [27]. After purification,
PSD proteins can be separated by SDS-PAGE (sodium dodecyl sulfate
polyacrylamide gel electrophoresis) or two-dimensional gel electrophoresis,
and major bands sequenced to identify abundant constituents such as
postsynaptic density-95 (PSD-95), calcium/calmodulin-dependent protein
kinase II (CaMKII), densin-180, synaptic GTPase-activating protein
(SynGAP), and actin [31].
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In recent years, large numbers of proteins in the PSD fraction or in
immunoprecipitated GluR complexes have been detected by mass
spectrometry

(MS)

methods,

desorption/ionization-time-of-flight

such

as

matrix-assisted

(MALDI-TOF)

MS

and

laser
liquid

chromatography (LC) coupled with tandem MS [32-38]. These experiments
estimate the number of PSD proteins in the range of a few hundred to as
many as one thousand.

However, this number includes many potential

contaminants, including mitochondrial and glial proteins.

Furthermore,

proteomic analysis of the PSD is likely to miss components that are in low
abundance or only transiently associated with PSDs. Finally, MS data do
not measure copy number of isolated proteins, which results in a
misrepresentation of the structural importance of a given postsynaptic
element. In order to address these issues, several experiments have aimed to
accurately quantify the number of proteins in the PSD.

For example,

quantitative electron microscopy (EM) and immuno-EM were used to
determine the size and molecular weight of the PSD, as well as protein
stoichiometry and distribution within the PSD [39, 40].

Based on the

accumulation of evidence from these studies it was possible to estimate the
likely number of different proteins in the PSD. That is, if a PSD were
composed solely of proteins of 100 kDa molecular mass, then there would
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be 10,000 proteins, or 100 copies each of 100 different proteins, in an
average PSD. This estimation reflects an important conclusion, based on
EM combined with quantitative immunoblotting, that the average PSD
contained 300 copies of the scaffold protein PSD-95 [41]. Thus, it is likely
that the available MS data have misrepresented the protein complexity of the
PSD due to false positives, false negatives, and the lack of stoichiometric
analysis.
Estimates of the number of proteins in the PSD that rely on bulk
separation from whole brain, even in the case of specific receptor coimmunoprecipitation, may falsely predict the protein complexity of the
postsynaptic specialization. Because the results reflect only the total number
and identity of all postsynaptic proteins, they might inaccurately depict the
structure of the PSD. To improve the study of postsynaptic proteins it is
crucial to enrich for only a subset of synapses, thus avoiding the additive
effects of bulk separation. Targeting PSD analysis to particular synapses in
only certain cell types or regions of the brain will result in more accurate and
meaningful data. Moreover, a comprehensive approach, in which distinct
PSDs are analyzed and then compared, will provide insight into the
functional roles of such proteins, rather than simply brand them as
generically postsynaptic. Single synapse-type analysis of the postsynaptic
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specialization is necessary in order to uncover the nature and mechanisms of
synaptic specificity.

Synaptic organization
In structuring a study of synaptic specificity, it is important to consider what
is already known about neuronal circuitry.

Cerebral cortex
Classification of cerebral cortical neurons originated two centuries ago.
Based on their appearance in Golgi-stained preparations, neurons were
characterized according to their size, shape, and dendritic branching pattern
[42]. The principal neuronal types of the cerebral cortex are the excitatory
pyramidal cells, which project to distant targets, and the inhibitory nonpyramidal cells, which are the cortical interneurons. Excitatory neurons
release glutamate as their neurotransmitter and exhibit a spiny dendritic
morphology, while inhibitory neurons are smooth and release the
neurotransmitter GABA. There are several types of spiny neurons including
the pyramidal, star pyramidal, Betz, and spiny stellate cells [15].
Immunohistochemical analysis revealed further details of the different types
of interneurons, generating a list of relatively simple but reliable markers
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[43]. Projection neurons have been classified by the laminar position of
their cell bodies, morphology, and electrophysiological characteristics [44],
but there are relatively few neurochemical markers available for their
identification. As illustrated in Figure 2, the laminar structure of the cortex
depends largely on the distribution of these various cell types.

Figure 2. Canonical cortical circuitry. Afferent fibers originating from
the thalamus terminate predominantly in layer IV.

Here they

glutamatergic spiny neurons, which are the main type of cortical input
neuron, and GABAergic smooth neurons. Layer IV spiny neurons relay
excitation to pyramidal cells in layer II/III. Within layer II/III, excitation
is distributed laterally and vertically to other cortical layers, in particular
to layer V. Layer II/III pyramidal neurons also contact each other. The
output from the cortex is relayed from layer V to subcortical brain regions
[13].
9

The major excitatory afferents to the cerebral cortex are from the dorsal
thalamus, which is arranged in nuclei that correspond to single or multiple
sensory modalities. The specific nuclei terminate mainly in layer IV and
lower layers II/III, with a separate and less dense set of collaterals in upper
layer VI. The non-specific (intralaminar) nuclei terminate densely in layers
V and VI. Spiny stellate cells, the major cell type of layer IV, are the
principal recipients of specific thalamocortical synapses. These cells in turn
project to other layer IV spiny stellate cells and to layer II/III pyramidal cells
[45]. The same cells that receive thalamic input are often projection neurons
as well; these are usually pyramidal cells. The output from a pyramidal cell
is specified by the layer in which the cell resides. The general rule of thumb
is that cortico-cortical connections arise mainly from the superficial cortical
layers and that subcortical projections arise from the deep layers [17, 46,
47]. Since the type of input to a cortical pyramidal neuron depends on its
laminar location, synaptic molecules may be specific to the layer in which
the postsynaptic cell is located. This laminar specificity would facilitate the
process by which incoming afferents form synapses only on cells of a
particular layer. A comparison of synaptic molecules based on the laminar
location of the postsynaptic may provide insight into the molecular nature of
such specificity.
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Laminar specificity is only one marker of neuronal identity. Within a
single cortical layer there exist distinct pyramidal cell populations. Genes
that regulate the production of cortical cell types have been identified [4850], but the molecular profile of a given neuronal cell type has remained
largely unspecified. Because of both molecular and genetic properties, the
pyramidal neurons of layer V prove particularly amenable to classification.
The large size of layer V cell bodies facilitates electrophysiological studies,
single cell RT-PCR, and cell filling to examine somatodendritic morphology
[51]. Pyramidal neurons of layer V of the adult rodent cortex fall into two
major classes, which can be distinguished by their projection site,
morphology, and physiological properties.

Type I cells project to the

superior colliculus, spinal cord, or basal pons; they are characterized by
thick tufted apical dendrites, and burst firing pattern.

Type II layer V

pyramidal neurons project to the contralateral hemisphere or to the
ipsilateral striatum. Their apical dendrites are slender with fewer oblique
branches that end without terminal tufts, usually in the upper part of layer
II/III, and they do not exhibit burst firing [52].

Since these distinct

projection neurons emerge sequentially within the very same layer, they
constitute a unique model system to study cortical neuron specification [51].
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Several techniques have been used to define protein markers of a
given layer V pyramidal cell population. In one study, a population of backlabeled or GFP positive cell bodies from layer V transgenic lines was sorted
and their gene expression profile was analyzed by microarray [53]. One
marker of type I layer V pyramidal neurons, Otx1, is a transcription factor
specifically expressed first in the ventricular zone and later in layer V and VI
neurons [54]. Otx1 is required for the refinement of layer V connections to
appropriate subcortical targets. In Otx1 null mice, the normally transient
pattern of exuberant connections is retained into adulthood [55].
Comparison between several transcription factors reveals distinct subsets of
pyramidal neurons within layer V, further subdividing Type I pyramidal
neurons into distinct classes. For example, retrograde tracing showed that
Er81 was expressed in corticospinal and corticocortical neurons, while Otx1
has been detected only in corticobulbar neurons [55].

The expression

pattern of Otx1 exemplifies the use of genetic markers to define
subpopulations of pyramidal neurons in cortex. In designing a study of
synaptic specificity, it is useful to first target a genetically defined class of
neurons. Analyzing only a particular synapse type within that class, which
can be defined based on both synaptic morphology and the expression of
particular synaptic markers, attains further specificity.
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Cerebellum
The cerebellum is a widely studied neuronal structure that has undergone
major elaboration throughout evolution and is essential for motor
coordination [15]. The basic organization of the cerebellum is that of an
interaction site between two distinct neuronal elements: the cerebellar nuclei
and cortex. The cerebellar cortex receives afferents from the climbing and
mossy fibers, while the main output is from the Purkinje cell (PC). Purkinje
cell axons make inhibitory synapses on the projecting cells of the cerebellar
nuclei [56].
The cerebellar cortex is divided into two distinct lamina: the
molecular layer, which contains the Purkinje cells, and the granular layer.
Climbing fiber afferents originate from a single brainstem nucleus, the
inferior olive, and contact Purkinje cell dendritic spines in the molecular
layer. Although each Purkinje cell receives only one climbing fiber input,
each inferior olive cell axon branches to form several climbing fibers. The
mossy fibers originate from a variety of CNS regions and synapse onto
several granule cells, which increases the number of Purkinje cells
stimulated by one mossy fiber axon. The granule cell axon projects towards
the molecular layer where it branches to form a parallel fiber that contacts
the dendrites of Purkinje cells.

These fibers are found throughout the
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molecular layer and synapse onto the Purkinje cell dendrites as well as the
dendrites of all other cells in the cerebellum, excluding granule cells [14,
57].

Figure 3.

Diagram of the cerebellar circuitry. Climbing fibers,

originating from the inferior olive, penetrate through the granular layer
and make excitatory synapses onto Purkinje cell dendrites. Granule cell
axons project through the Purkinje cell layer to form the parallel fibers in
the molecular layer.

Parallel fibers make excitatory contacts on the

Purkinje cell dendrites. The basket and stellate cells make inhibitory
synapses onto Purkinje cell bodies. Excitatory synapses are denoted by
(+) and inhibitory synapses by (-). MF: Mossy fibers. DCN: Deep
cerebellar nuclei. IO: Inferior Olive. CF: Climbing fiber. GC: Granule
cell. PF: Parallel fiber. PC: Purkinje cell. GgC: Golgi cell. SC: Stellate
cell. BC: Basket cell [14].
14

The cerebellum comprises several other cell types that can be
distinguished in part based on their laminar specificity. The granular cell
layer contains granule cells, which are contacted by mossy fiber axons, and
Golgi cells, which form inhibitory synapses onto granule cells. The Purkinje
cell layer contains basket cells, which make inhibitory synapses onto the
somata and initial segments of Purkinje cells and spiny cells, which make
inhibitory synapses onto Purkinje cell dendrites [56].
The architecture of climbing fiber and parallel fiber inputs
demonstrates the disynaptic input to the Purkinje cell. Each Purkinje cell
receives input from a single climbing fiber, whose afferents branch to
“climb” along the entire dendritic tree, repeatedly contacting Purkinje cell
dendritic spines. Morphologically, the presence of a climbing fiber synapse
seems to exclude nearby parallel fiber-Purkinje cell contacts, thus dividing
the dendrites into a central area covered by the climbing fibers, and a
peripheral spiny portion that is contacted by parallel fibers. The distinct
anatomy of these two excitatory inputs, as well as their molecular and
functional differences (see below), make the Purkinje cell a useful model for
the study of synaptic specificity.
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Hippocampus
The hippocampus is located inside the medial temporal lobe of the cerebral
cortex, forming part of the telencephalon (forebrain). It belongs to the
limbic system and plays major roles in short term memory and spatial
navigation [58]. As shown in part in Figure 4, the hippocampus and related
areas comprise six distinct structures: entorhinal cortex (Ent), parasubiculum
(PaS), presubiculum (PrS), subiculum proper (S), fields CA1-CA3 in
Ammon’s horn (Amn), and dentate gyrus (DG) [21, 58]. Neurons from
layer two of the entorhinal cortex send afferents to the hippocampus via the
perforant path, which terminate in the dentate gyrus and CA3. There is also
a distinct pathway from layer 3 of the entorhinal cortex directly to CA1.
Granule cells of the dentate gyrus send their axons, known as mossy fibers,
to CA3. CA3 axons branch to form the Schaffer collateral, which contacts
neurons of CA1. Pyramidal cells of CA1 send their axons to the subiculum
and deep layers of the entorhinal cortex, thus completing the circuit. The
hilus (h), also known as CA4, is a transition area between CA3 and the
dentate gyrus and contains several types of pyramidal cells, including
scattered mossy cells and basket cells. The mossy fibers make excitatory
connections on the hilar basket cell neurons, which in turn form mainly
inhibitory synapses on the granule cells. It has been suggested that the
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reciprocal connection between granule cells and basket cells forms an
inhibitory feedback circuit [59, 60].

Figure 4. Connectivity in the hippocampus. Perforant path (pp) is
shown in brown. Afferents from the entorhinal cortex (EC) innervate the
outer molecular layer (oml) of the dentate gyrus (DG) and stratum
lacunosum molecular (lm) layer of the cornu ammonis (CA). Mossy fiber
(mf) pathway is shown in blue. These fibers connect DG with CA3.
Schaffer collaterals (Sch) are shown in pink. Abbreviations: a, alveus; p,
stratum pyramidale; SUB, subiculum. Circuitry diagram from review by
T. Skutella and R. Nitsch [21].

In the hippocampus, as well as in the cerebellum and cerebral cortex,
synaptic circuitry is further specified by the presence of particular
neurotransmitter receptors. In particular, the properties and distribution of
AMPA and GABA receptors is instructive to the study of synaptic
specificity in these various brain regions.
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Excitatory synapses: AMPA receptors
The glutamate receptor family comprises a diverse group of excitatory
neurotransmitter receptors. Twenty-eight recombinant glutamate receptor
(GluR) cDNAs plus a considerable number of splice variants thereof have
been cloned. These 28 GluR genes include 22 members of the ionotropic
subfamily as well as six metabotropic receptors [16]. A major class of
glutamate receptors is the ionotropic AMPA receptor, which contains a
cation-specific ion channel. The four AMPA receptor subunits, GluR1GluR4, contain a large extracellular N-terminal domain, four hydrophobic
membrane

segments,

and

an

intracellular

C-terminus,

as

shown

schematically in Figure 5 [61]. AMPA receptors are either homomeric or
heteromeric oligomers composed of multiple subunits. Only two distinct
subunits are usually found in a given receptor. Differences in the functional
properties of native AMPA receptors result from variable assembly of these
subunits. For example, all AMPA receptors are permeable to Na+ and K+,
but homomeric receptors assembled from GluR2 subunits display little
permeability to Ca++, while heteromeric receptors assembled from GluR2,
GluR3 or GluR4 are highly permeable to Ca++. In this way, the GluR2
subunit is considered to regulate Ca++ permeability of the AMPA receptor
[62].
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Figure 5. AMPAR subunit conformation. The four AMPA receptor
subunits, GluR1-GluR4, contain a large extracellular N-terminal
domain, four hydrophobic membrane segments, and an intracellular Cterminus. Variation in C-terminal sequences of the various subunits
results in binding to differential interacting proteins [16].

Because differential subunit assembly results in distinct AMPA
receptor functional properties it is of interest that each subunit is not
uniformly expressed in all cortical laminae. Studies by in situ hybridization
as well as immunohistochemistry have elucidated the expression patterns of
GluR1-GluR4 subunits in the rodent brain, as summarized in Table 1 [7-9].
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Differential receptor assembly will confer specific properties to the
glutamatergic synapses in distinct areas of the brain.
Table 1. Distribution of AMPA receptor subunits.
region/cell type
cortex
layer I
layer II/III
layer IV
layer V
pyramidal n.
nonpyramidal n.
hippocampus
CA1
CA3
DG
striatum
spiny n.
aspiny n.
cerebellum
purkinje cells
granule cells
golgi cells
stellate/basket cells
bergmann glia

Table

1:

GluR1

Distribution

GluR2

GluR3

+++
+++
+
+++
+++

+
+
+
++

+++
+++

+++
+++

+++
+++

++
+++

+++

+++

+++
+++

+++

+
+
+
+
+++

GluR4

+++

AMPA

+
+
+++

++

+

of

++
++

receptor

++
++

subunits.

Immunohistochemical studies using antibodies against specific GluR
subunits show that GluR1 and GluR3 expression is low in layers III and
IV, while GluR4 expression is high in these layers. GluR2 is distributed
uniformly. GluR1 immunoreactivity is low in layer IV, and GluR2/3/4c
immunoreactivity is enriched highly in layers I, II, and III, low in layer
IV, and enriched in deep layer V. Differences exist in other non-cortical
structures as well [7-9].

20

GluRδ2
GluRδ was found as a novel member of GluR channel family by molecular
cloning [63].

GluRδ2, the second member of the GluRδ subfamily, is

selectively expressed in Purkinje cells of the cerebellum [64] and within
cerebellar Purkinje cells (PCs), GluRδ2 is localized postsynaptically at
parallel fiber-Purkinje cell synapses, but not at climbing fiber-Purkinje cell
synapses [65]. With respect to the amino acid sequence identity, the GluRδ
subtype is positioned between the NMDA and non-NMDA subtypes [64].
However, GluRδ2 has been referred to as an orphan receptor because it does
not form functional glutamate-gated ion channels when expressed in
transfected cells, either alone or with other GluRs, nor does it bind to
glutamate analogs [64].

This receptor is predominantly expressed in

Purkinje cells, and is crucial to cerebellar function. Mice that lack the gene
that encodes GluRδ2 [66] display ataxia and impaired long-term depression
(LTD), a putative cellular model of cerebellar information storage [67].
Despite their importance, the mechanisms by which GluRδ2 receptors
participate in cerebellar function are not well understood.
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AMPA receptor interacting proteins
The class of AMPA receptors present at a given synapse type is one
determinant of synaptic specificity. Further refinement is achieved though
the interactions of the receptor with postsynaptic molecules. Many AMPA
receptor binding proteins have been discovered using the yeast-two hybrid
system, confocal microscopy and electrophysiology. A description of a
subset of such molecules follows below.
PSD95
The proteins found to interact with AMPA receptors can be roughly divided
into two groups; those containing PDZ domains and those that interact
through alternative sequences.

The PDZ domain is a protein–protein

interaction motif of approximately 90 amino acids [31]. The scaffolding
function of PDZ domain-containing proteins is exemplified by PSD95. It
contains three PDZ domains, an src-homology 3 (SH3) domain, and a
guanylate kinase domain, which also acts as a protein interaction module.
This multivalent structure allows PSD95 to arrange integral membrane
proteins, including NMDA receptors, Shaker-type potassium channels, and
the postsynaptic cell adhesion molecule, neuroligin.

PSD95 also likely

functions to recruit functional mediators such as synGAP and neuronal nitric
oxide synthetase and anchoring proteins such as CRIPT [68].
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PSD95

contains a number of domains to bring a variety of proteins into close
proximity to each other, providing a means to cluster, anchor, and regulate
receptors.
GRIP and APB
GRIP (glutamate receptor interacting protein) was the first protein shown to
interact with AMPA receptors by the yeast two-hybrid system. Cloning of
GRIP has demonstrated that it is a 130 kDa protein that contains seven PDZ
domains, of which the fourth and fifth mediate binding to the C-termini of
GluR2 and GluR3 [69, 70].

AMPA receptor binding protein (ABP) is

related to GRIP in structure and shares 64–93% homology in the PDZ
domains [71]. The functional implications of the interaction between GRIP
and AMPA receptors remain unclear. GRIP was proposed to have a role in
the clustering of AMPA receptors, even though not all clusters of AMPA
receptors contain GRIP immunoreactivity [69]. In heterologous expression
systems ABP and GRIP alone do not aggregate with GluR2 despite
interacting strongly [71]. The fact that GRIP has multiple PDZ domains
suggests that it may function in bringing proteins together which are
important in synaptic localization and clustering, especially at certain times
in development or activity.
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Stargazin
The first transmembrane protein found to interact with AMPARs is
stargazin, which is a member of a family of transmembrane AMPAR
regulatory proteins (TARPs) that regulate the trafficking and physiology of
AMPARs [72].

Stargazin is mutated in stargazer mice, which display

absence epilepsy and lack functional AMPARs in cerebellar granule cells
[73]. Stargazin plays two roles in trafficking AMPARs to synapses. First,
stargazin can associate with all four AMPAR subunits and traffic them to the
plasma membrane. Second, the extreme COOH terminus of stargazin can
bind to PSD-95 and other PDZ proteins to mediate synaptic clustering of
AMPARs [74]. The expression patterns for TARP family proteins in the
central nervous system appear to cover all populations of neurons and glia
that express AMPA receptors, suggesting a general role for this regulatory
mechanism.
Homer
Homer acts as a postsynaptic adaptor protein that links multiple targets,
including proteins involved in glutamate receptor signaling [75]. Alternative
splicing results in two predominant forms of the Homer protein. The short
Homer forms lack the carboxy-terminal domain and are expressed in an
activity-dependent manner [76].

The long forms are constitutively
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expressed and consist of two major domains: the amino-terminal targetbinding

domain,

which

includes

an

Enabled/vasodilator-stimulated

phosphoprotein (Ena/VASP) homology 1 (EVH1) domain, and the carboxyterminal self-assembly domain containing a coiled-coil structure and leucine
zipper motif. These long Homer proteins form multimers that are thought to
cluster other synaptic proteins, a process that may be required for synaptic
function [77].
Shank
ProSAP/Shank

molecules

are

early

components

of

postsynaptic

specializations present during synaptogenesis. They are efficiently targeted
to synaptic sites and contain several protein-protein interaction domains,
namely ankyrin repeats, an SH3 and PDZ domain, proline-rich stretches, and
a SAM (sterile alpha motif) domain [78].

The AMPA receptor GluR1

subunit has recently been reported to interact directly with the PDZ domain
of Shank [79] attaching the AMPAR complex to the other GluR complexes.
GluRδ2 has been shown to interact with Shank protein by a yeast twohybrid

screen

and

this

interaction

was

confirmed

with

co-

immunoprecipitation experiments from synaptosomal plasma membrane
(SPM) fractions collected from mouse cerebella [80].
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The function of Shank protein in the cerebellum is likely related to the
fact that it binds to Homer and GRIP [81]. It is known that Homer binds
mGluR1α [82], whereas GRIP interacts with GluRδ2 [69]. Thus, Shank may
organize mGluR1 and ionotropic AMPA receptors into a complex that is
critical for cerebellar LTD induction.

Immunoprecipitation experiments

with SPM fractions of cerebella showed that GluRδ2 indeed forms a protein
complex with Homer and mGluR1α in vivo [80]. These results suggest that
GluRδ2 regulates cerebellar synapse dynamics through the interaction with
Shank proteins.

Insertion of AMPA receptors into the synapse
The type and number of AMPA receptor subunits present at a given synapse
is variable, and depends on experience and age of the organism [83].
AMPARs are characterized by their ability to move into and out of the
postsynaptic membrane in a subunit-dependent fashion [84]. This AMPAR
trafficking, which requires regulated endo- and exocytosis, depends not only
upon receptor subunits and interacting proteins, but also upon the nature of
synaptic stimulation or neuronal cell types [85]. It has been reported that
receptors containing the GluR1-subunit are added to hippocampal synapses
in an activity-dependant manner, a process that requires interactions between
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GluR1 and group I PDZ domain proteins [86]. In contrast, GluR2/GluR3
receptors replace existing synaptic receptors in a constitutive manner
dependent on interactions by GluR2 with NSF and group II PDZ domain
proteins [87]. Experiments in the mouse barrel cortex demonstrated this
process in vivo. Experience-dependent increases in synaptic strength at layer
IV to II/III synapses were prevented by expression of a peptide that inhibits
protein interactions with the intracellular C-terminal tail of GluR1 [88].
These findings suggest crucial differences in the regulation of AMPAR
subunit delivery to synapses.
Differences in domain organization of GluR1 and GluR2 subunits can
partially account for differences in their regulation. Two distinct C-terminal
interaction

domains

on

GluR2

have

been

characterized:

an

N-

ethylmaleimide-sensitive fusion factor (NSF)-binding site and an extreme Cterminal PDZ-binding motif (ct-GluR2/3 PDZ). The PDZ-binding motif has
namely, GRIP, ABP, and protein interacting with C-kinase 1 (PICK1) [89,
90]. GluR1, GluR3 and GluR4 do not interact with NSF, which has been
shown to be involved in various membrane fusion events, such as exocytosis
of synaptic vesicles.
The above examples illustrate differences in interacting proteins of the
various AMPA receptor subunits; however, most studies to date have been
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limited to a particular subunit in a particular cell type. Furthermore, with the
exception of the TARPs, most interacting proteins have been characterized
with respect to trafficking of receptor subunits, rather than their channel or
signaling functions. While such studies suggest the existence of significant
differences between the interacting proteins of individual subunits, a
comprehensive approach to characterize such differences has not been
carried out. By isolating distinct populations of GluR-containing synapses
from the intact brain and analyzing their protein content, it will be possible
to elucidate such differences on a larger scale.
Inhibitory synapses: GABAA receptors
The GABAA receptor is a ligand-gated chloride ion channel, comprising five
subunits selected from a pool of 19 distinct gene products [91]. Subunit
rules for GABAA receptor assembly have emerged, with the largest group of
GABAA receptors being made up of α1γ2- and a β-subunit [10]. GABA
neurotransmitter acts as an agonist, binding extracellulary between the α and
β subunits and inducing a conformational change that increases permeability
to chloride ions. Each subunit consists of a short extracellular C-terminus, a
large extracellular N-terminus, four transmembrane domains (TM1-TM4)
and a large variable-sized cytoplasmic loop between TM3 and TM4, as
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illustrated in Figure 6.

The intracellular loop contributes most of the

cytoplasmic domain of the GABAA receptor and includes multiple proteinprotein interaction sites for trafficking and postsynaptic scaffold proteins and
phosphorylation sites for diverse serine, threonine and tyrosine kinases [11].
The amphiphilic TM2 domain provides the lining of the ion pore within the
pentameric structure [10].

Figure 6. GABAA receptor subunit composition. Receptor subunits
consist of four hydrophobic transmembrane domains (TM1-4), where
TM2 is believed to line the pore of the channel.

The large

extracellular N-terminus is the site for ligand binding as well as the
site of action of various drugs. Each receptor subunit also contains a
large intracellular domain between TM3 and TM4, which is the site for
various protein-protein interactions as well as the site for posttranslational modifications that modulate receptor activity [10, 11].
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Many substances act as modulators of GABAA receptors. Benzodiazepines
are characterized by their anxiolytic, anticonvulsant, sedative, and amnesic
effects. They enhance the GABA-induced chloride current by allosteric
modulation, increasing the frequency of chloride channel opening.
Barbiturates, on the other hand, prolong the duration of chloride channel
opening [92]. The particular subunit composition of the receptor influences
its pharmacological properties. For example, receptors composed of α1 or
α2γ2β subunits respond to benzodiazepine and nonbenzodiazepine
anxiolytics. In contrast, receptors lacking γ subunits, or those γ-subunits
combined with α4 or α6, are generally insensitive to the benzodiazepines
and related drugs [93].
The expression of GABAA receptor subtypes is spatially, regionally,
and developmentally regulated, with individual subunits having distinct but
overlapping expression patterns, as summarized in Table 2 [1-4]. In addition
to differential subunit expression throughout brain regions, the GABAA
receptor subunit composition varies between cell types and undergoes
differential subcellular targeting. The α4, 5, 6, and δ-containing subunits
are located extrasynaptically and are responsible for the tonic inhibitory
current (persistent: long-term GABAA exposure at low concentrations),
while all of the other GABAA receptor subunits—especially the γ2-subunit
30

containing GABAA receptors—are preferentially expressed on the synaptic
site and are involved in phasic inhibition (transient: short-term GABA
exposure at high concentrations) [94].
Table 2. Immunohistochemical distribution of GABA receptor
subunits throughout the mammalian brain [1-4].
GABAAR Cerebral
Subunit
Cortex
α1
+++
α2
++
α3
+
α4
++
α5
+
α6
β1
++
β2
+++
β3
+++
γ1
γ2
+++
γ3
+
δ
+++

Cerebellum
(PC layer)

Cerebellum
(Mol. Layer)
+++
++

+

++
++
+
+

+

Hippocampus
(CA1)
+++
++
++
+++

Hippocampus
(CA3)
+++
+++
+
++
+++

++
+++
+++

+++
+++
+++

+++
+
+

+++
+
+

+
+
++

++

The significance of the structural diversity of GABAA receptors remains
unknown. One intriguing possibility is that the diversity in GABAA receptor
subunits is important for mediating subcellular localization. Differential
subcellular targeting of GABAA receptors is best documented in
hippocampal pyramidal neurons. Here, receptors that contain α1 subunits
seem to be equally distributed at all inhibitory synapses on the neuronal
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somata, the proximal and distal dendrites, the spines, and the axon initial
segments. By contrast, receptors that contain α2 subunits are preferentially
localized at axo-axonic synapses on the axon initial segments [95, 96]. The
subunit-specific targeting of GABAA receptors has also been analyzed in
cerebellar granule cells, which express a range of subunits, including α1, α6,
β2, β3, γ2 and δ; these subunits can assemble as α1/β2/3γ2 or α6/β2/3δ
combinations [4]. Receptors that contain δ subunits are specifically targeted
to extrasynaptic domains [97, 98], whereas receptors that contain the γ2
subunit are localized to synaptic sites on granule cells [99]. In addition to
differential subcellular trafficking of the various GABA receptor subunits,
receptor diversity likely confers specificity of GABA receptor interacting
proteins.

GABAA receptor interacting proteins
While the structure and pharmacology of the GABAA receptors has been
widely studied, analysis of the protein components of inhibitory synapses
has been limited. Studies to identify GABAA receptor interacting proteins
have relied heavily on in vitro methods, such as the yeast two-hybrid system
and heterologous cell expression systems. A summary of some of the major
interacting partners follows below.
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GABARAP
GABARAP is a GABAA receptor-associated and microtubule-associated
protein originally found in a yeast two-hybrid system using the intracellular
loop of γ2 as bait [100].

GABARAP is enriched predominantly in

intracellular membranes including the Golgi apparatus and postsynaptic
cisternae. It is not found at significant levels within inhibitory synapses
[101, 102]. Functionally, GABARAP acts as a linker protein between the
microtubule protein tubulin and the intracellular loop of the γ2 subunit,
which promotes the clustering of γ2-subunit containing GABAA receptors
[100]. In addition, GABARAP has a basic N-terminus that can bind to
tubulin and an ubiquitin-like C-terminal γ2 subunit-binding region.
Additional binding partners of this multifunctional adapter molecule include
gephyrin, GRIF-1, NSF, PRIP-1, and ULK1 [103, 104].
Gephyrin
Gephyrin was originally found to anchor glycine receptors to the
postsynaptic cytoskeleton [105]. Like GABARAP, gephyrin is a tubulinbinding protein, and is involved in organizing postsynaptic GABAA
receptors at inhibitory GABAergic synapses [28, 106].

Gephyrin is

concentrated in the postsynaptic membrane at many inhibitory synapses and
has been shown to colocalize with GABAA receptors [98], but a direct
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interaction by co-immunopurification has not been demonstrated [107].
GABARAP binds gephyrin and GABAA receptors directly, suggesting that
GABARAP might function as the adaptor for the association of these two
proteins.

Studies of the mechanisms for clustering of major GABAA

receptor subclasses at GABA-dependent synapses have demonstrated that
both the γ2 subunit of GABAA receptors and gephyrin are involved in
receptor clustering, targeting and localization [108].

One study also

revealed that synaptic GABAA receptors have lower levels of lateral
mobility as compared to their extrasynaptic counterparts, and suggests a
specific role for gephyrin in reducing the diffusion of GABAA receptors,
facilitating their anchoring at inhibitory synapses [109]. Gephyrin is not
required for clustering of all GABAR subunits, as demonstrated by a study
of receptor localization in neurons of gephyrin deficient mice [110]. The
punctate staining of GABAA receptor α1 and α5 subunits was unaltered in
mutant mice, whereas the numbers of α2-, α3-, β2/3-, and γ2-subunitimmunoreactive synaptic sites were significantly reduced.

This result

demonstrates that additional mechanisms for GABAA receptor clustering
may be revealed by studies of subunit-specific interacting proteins.
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Profilin and mENA/VASP
Neuronal gephyrin has also been shown to interact directly with key
regulators of microfilament dynamics, such as profilins I and IIa, and with
microfilament adaptors of the mammalian enabled (mENA)/vasodilator
stimulated phosphoprotein (VASP) family, including neuronal mENA.
Profilin and mENA/VASP coprecipitate with gephyrin from brain tissue and
cultured cells. Gephyrin, profilin, and Mena/VASP colocalize at synapses of
rat spinal cord and cultivated neurons and in gephyrin clusters expressed in
transfected cells [111]. Thus, mENA/VASP and profilin can contribute to
the postulated linkage between receptors, gephyrin scaffolds, and the
microfilament system and may regulate the microfilament-dependent
receptor packing density and dynamics at inhibitory synapses.
GRIP-1
GRIP-1, which was first found in the glutamatergic system, also interacts
with the γ2 subunit of GABAA receptors [69]. It exists in various splice
forms, which localize differently in the intact brain. It has been reported that
GRIP1a/b localized to both GABAergic and glutamatergic synapses in
cultured hippocampal neurons [69, 70], but not to GABAergic synapses in
the intact brain [70]. GRIP1c is found to be present at excitatory synapses in
both

cultured

neurons

and

intact

35

brain

as

demonstrated

by

immunofluorescence and electron microscopy. Contrary to the other GRIP
isoforms, it also localizes to GABAergic synapses, suggesting a possible
role in GABAergic transmission. GRIP1c does not co-immunoprecipitate
with any GABAA receptors from brain extract, but rather with AMPA
receptors [112]. GRIP1c might interact with GABAA receptors through
GABARAP or other GABAA receptor associated proteins to participate in
GABAA receptor trafficking and clustering.

Its exact role at inhibitory

synapses remains unknown, although its ability to interact with GABARAP
suggests that it may be involved in the synaptogenesis of inhibitory synapses
or in the regulation of GABAA receptor function [104].
PRIP-1
PRIP-1 (Phospholipase-C related catalytically inactive protein type-1) is an
inositol 1,4,5-trisphosphate-binding protein similar in domain organization
to phospholipase C-δ1 but lacking PLC activity.

PRIP-1 competitively

inhibits the binding of the γ2 subunit of GABAA receptors to GABARAP,
suggesting that this protein participates in GABAA receptor assembly and
transport to the cell surface [113].
PLIC-1
Plic-1, is associated with the ubiquitination-degradation machinery
(proteasome/ubiquitin-ligase), and contains a ubiquitin-like N-terminus that
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is 33% identical to ubiquitin [114]. It also contains a carboxy-terminal
ubiquitin-associated domain that interacts directly with the intracellular loop
of the α- and β-subunit containing GABAA receptors. Functionally, Plic-1
facilitates GABAA receptor membrane insertion by increasing the half-life of
intracellular receptor pools without modifying receptor endocytosis [114].
GRIF-1
GRIF-1 (GABAA receptor interacting factor-1) is a member of a coiled-coil
domain family of proteins thought to function as adaptors in the anterograde
trafficking of organelles utilizing the kinesin-1 motor proteins to synapses.
GRIF-1, has been shown to interact with the intracellular loop of the β2
GABAA receptor subunit [115].
GODZ
The large intracellular loop of the γ2 subunit is rich in cysteine residues,
which are absent from the equivalent domain of all the other subunits [24],
suggesting that it might be a candidate for palmitoylation. Recent work
demonstrated that the γ2 subunit is palmitoylated on five cysteine residues in
the large intracellular loop [116, 117].

Palmitoylation is required for

controlling both GABAA receptor clustering at synaptic sites and for the cell
surface stability of these proteins in neurons. GODZ (Golgi-specific DHHC
zinc finger protein) is a GABAA receptor interacting protein, which acts as a
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neuron-specific thioacyltransferase that palmitoylates the intracellular loop
of the γ2-subunit containing GABAA receptor [116].
AP2
Dynamin-dependent endocytosis is important in the regulation of cell
surface levels of a number of integral membrane proteins and involves their
recruitment into clathrin-coated pits by adaptor proteins. Internalization of
GABAA receptors is mediated by clathrin-dependent endocytosis. Recent
studies have demonstrated that GABAA receptors associate with the adaptin
complex protein, AP2, and colocalize with AP2 in cultured hippocampal
neurons [118]. This interaction is mediated by the GABAA receptor γ2
subunit, at a site specific for tyrosine phosphorylation [119], and the µ2
subunit of AP2 [120].

The above examples of GABAR- and AMPAR-interacting proteins
demonstrate the importance of neurotransmitter receptor-interacting proteins
in synaptic specificity and function. In addition, there are many proteins
present at the synapse that do not directly interact with receptors, such as the
neuroligin family of cell adhesion molecules. Further study of synaptic
proteins will be crucial to broadening our understanding of the nervous
system.
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Synaptic specificity
The mechanism by which billions of neurons accurately form complex
circuitries remains an area of intense study. It is clear that developmental
genetic programs play a key role in establishing synaptic circuitry. Many
molecules involved in axon guidance and synaptogenesis have been
identified and their functions described [121, 122]. However, most of these
molecules are found ubiquitously throughout the nervous system and are
generic components of synapse formation, rather than markers of specific
synaptic connections.
One feature necessary for synaptic heterogeneity is cell-type specific
expression of a protein, and targeting of that protein to all presynaptic or
postsynaptic sites made by a cell. On the presynaptic side, neurotransmitter
synthetic enzymes and vesicular and plasma membrane transporters that
determine the chemical nature of a synapse generally fall into this category.
For example, the GABA synthetic enzyme glutamic acid decarboxylase
(GAD65 and GAD67), the vesicular inhibitory amino acid transporter
responsible for loading GABA into vesicles (VIAAT/VGAT), and the major
plasma membrane transporter responsible for reuptake of GABA (GAT-1)
are found at symmetric but not asymmetric synapses [123-126]. In situ
hybridization studies indicate this is due primarily to expression by
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GABAergic but not glutamatergic neurons [127, 128]. Thus, expression of a
small number of genes or even a single gene can determine presynaptic
transmitter phenotype.
In addition to genetic determinants, morphological constraints
can direct specific synapse formation. Certain subcellular domains can be
permissive for specific synapse types and even selective for particular
receptors. For example, the axon initial segment of hippocampal pyramidal
cells is permissive (or perhaps instructive) for formation of GABAergic but
not glutamatergic postsynaptic sites [129].

Furthermore, GABAergic

synapses on the axon initial segment have a higher density of the GABAA
receptor α2 subunit than do GABAergic synapses on dendrites of the same
cell, whereas the α1 subunit is more uniformly targeted to both
somatodendritic and axon initial segment GABAergic synapses. The results
demonstrate that granule cells receiving GABAergic synapses at a restricted
location on their distal dendrites exhibit a highly compartmentalized
distribution of GABAA receptor in their plasma membrane [130].

The

mechanism by which this differential subunit distribution is maintained
could be uncovered by subunit-specific co-immunoprecipitation from
hippocampal pyramidal neurons, followed by mass spectrometric analysis to
identify unique interacting partners.
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Another excellent example of specific localization of inhibitory inputs
is found in the Purkinje cells of the cerebellum. These neurons receive two
sets of GABAergic inputs: the basket and stellate interneurons. The stellate
cells selectively innervate Purkinje cell dendrites, while the basket cells
project to the axon initial segment, forming the so-called ‘pinceau synapses.’
Using BAC transgenic mice in which basket cells were labeled throughout
their development, pinceau synapse targeting was found to be achieved
through multiple steps [131]. Basket axons first contact the Purkinje cell
soma and subsequently migrate down towards the axon initial segment. This
migration was found to be dependant on a gradient of neurofascin, a member
of the L1 subfamily of immunoglobulin proteins, which was found to
emanate from the AIS towards the soma and dendrite. The specificity of
basket cell innervation demonstrates the subcellular targeting of inhibitory
terminals and the role of guidance cues in development of synaptic
specificity.
Even within a single class of synapse (a single presynaptic cell type
making synapses onto a single postsynaptic cell type), there exists a
heterogeneity of features.

As in the case of GABAA receptor subunit

distribution, differential GluR subunit distribution also contributes to
synaptic specificity. One example is the variability in postsynaptic AMPA
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type glutamate receptor content in hippocampal pyramidal neurons.
Quantitative electron microscopy studies of CA3 Schaeffer collateral
synapses

onto

immunoreactive,

CA1
67%

neurons

found

moderately

19%

of

synapses

immunoreactive,

and

strongly
17%

immunonegative for AMPA receptors [132].

Immunonegative synapses

were exclusively the smaller synapses [133].

Because every Schaeffer

collateral synapse onto CA1 pyramidal cell spines contains NMDA receptors
[133, 134], a subset of these synapses express only NMDA receptors and
could correspond to the anatomical substrate for the electrophysiologically
defined 'silent synapses' [135]. These observations suggest that the targeting
mechanisms and the regulation of cell surface expression of these two types
of glutamate receptors follow different rules. Indeed, recent studies indicate
that, unlike NMDA receptors, AMPA receptors are highly mobile in a short
time scale and that these dynamic properties are relevant for the observed
heterogeneity in AMPA receptor synapse composition and could have an
important part in mediating different forms of synaptic plasticity.
Although there are limited examples of non-receptor molecules for
synaptic specificity in the mammalian nervous system, one important family
of cell adhesion molecules, the neuroligins (NLs) have been shown to
possess some differential synaptic expression. In vitro functional studies
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indicate that an interaction between β-neurexin and neuroligins can trigger
synapse initiation. Axons from pontine explants form presynaptic vesicle
clusters when they come into contact with non-neuronal cells that express
neuroligin-1 or neuroligin-2 [136].

Neuroligin family members are

differentially spliced, an observation that gave rise to the idea that
differential localization and binding between them could serve to specify
synapses.

For example, neuroligin-2 (NL-2) is a postsynaptic adhesion

molecule that localizes at GABAergic synapses and triggers synapse
formation by interacting with presynaptic neurexins [137, 138], while
neuroligin-1 (NL-1) is targeted to glutamatergic synapses [136, 139]. This
differential expression may play an important role in specifying distinct
types of synapses and in determining a balance between neuronal excitation
and inhibition [140].

The mechanisms responsible for the differential

targeting of NL-1 to glutamatergic synapses and NL-2 to GABAergic
synapses are unclear, although there is evidence that such specificity could
arise from intracellular interactions with postsynaptic scaffolds [140].
However, the binding partners of NL-2 at GABA synapses are not known.
Further evidence for the role of synaptic adhesion molecules has
proven elusive, even though Sperry’s 1963 Chemoaffinity Hypothesis
proposed their function in specifying synapses [141].
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Recent work

identified SYG-1 in a genetic screen for Caenorhabditis elegans mutants
defective in synaptic positioning [142]. In SYG-1 mutants, the neurons that
synapse on vulval muscles fail to cluster synaptic vesicles at their normal
sites of synaptic contact; instead, vesicles are clustered at several ectopic
sites. Vesicle clustering (and thus presumably synapse formation) at the
correct location requires SYG-1-dependent contact with vulval epithelial
guidepost cells, which may express specific receptors for SYG-1. SYG-1 is
likely to be the C. elegans orthologue of vertebrate NEPH1 [143], which are
expressed in the CNS [144] and could play roles in synaptogenesis.
The experiments described above exemplify recent approaches to the
study of synaptic specificity, a crucial area in the field of neurobiology. In
order to elucidate the mechanism by which neurons form and maintain
appropriate contacts it will be necessary to expand our understanding of
synaptic proteins beyond neurotransmitter receptors and other ubiquitous
components. Furthermore, neurobiological disease often results from cellor synapse-specific dysfunction [67, 145], necessitating an experimental
approach that can target only the relevant structures. In light of these issues,
we have designed a novel approach to the study of the postsynaptic
specialization in the adult mammalian CNS.
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A novel approach to the study of synaptic specificity
Previous studies into the complexity of the postsynaptic specialization and
the methods of generating synaptic specificity are limited in scope.

A

comprehensive approach to the nature of synaptic specificity in the
mammalian brain has yet to be developed. To address this issue, we have
developed a novel approach that is schematically outlined in Figure 7.

Cell-specific expression of a synaptic affinity tag
In order to purify a single class of synapse, it was necessary to first identify
a transmembrane protein with synapse specific expression. As discussed
above, this is likely to be a particular neurotransmitter receptor, as in the
case of the cerebellar Purkinje cell molecule, GluRδ2, which is found only at
the parallel fiber-Purkinje cell synapse. The cDNA for a particular receptor
subunit was N-terminally fused to cDNA for an affinity tag, Venus, a YFP
variant. Several groups have demonstrated that such a fusion protein, with
GluR2 for example, is efficiently translated and inserted into the synaptic
membrane as a functional receptor [83, 90]. The constructs were analyzed
for expression and insertion into the membrane by transformation in
heterologous cells followed by immunocytochemistry and immunoblotting.
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Figure 7. Novel scheme for tagging and isolation of particular
synapses. Through a BAC transgenic approach, mice are generated that
express a receptor-GFP fusion protein targeted to a single synapse type in
a single cell type. After biochemical purification of the postsynaptic
specialization, the tagged synaptic complexes are affinity purified using
an anti-GFP antibody.

Protein components are identified by mass

spectrometry.

To generate transgenic mice with cell-specific expression of a given
Venus-receptor fusion protein, we relied on the bacterial artificial
chromosome (BAC) transgenic approach [6, 146]. In this system, the fusion
construct is inserted into the BAC downstream of the complete regulatory
elements of a gene endogenously expressed in the neurons of interest. The
GENSAT [5] project has generated thousands of BAC lines that express
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GFP alone. An analysis of the expression patterns of such lines was used to
select BACs that drive expression only in neuronal subpopulations of
interest. Figure 8 shows several of the BAC lines selected, and the particular
cell types targeted by that line [5].
We relied on SDS-PAGE and immunoblotting of whole brain extract
as well as immunohistochemistry of fixed brain sections to verify expression
of the receptor-Venus fusion protein in the transgenic animal. In some cases
immuno-electron microscopy was used to validate appropriate subcellular
targeting of the receptor fusion protein to the correct synapse type. Once
expression of the fusion protein in a given transgenic line was confirmed, we
went on to biochemically purify the tagged synaptic protein complexes.
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Figure 8. Selection of BAC drivers for cell type specific expression.
Each BAC transgenic line expresses GFP in a particular cell type
(arrow). By replacing the GFP coding region with that for a given
protein of interest it is possible to target transgene expression to a
particular neuronal cell population [5, 6].
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Purification of targeted postsynaptic protein complex
In order to identify proteins at the synapse, rather than other subcellular
compartments in which our fusion protein is localized, it was necessary to
first enrich for the postsynaptic specialization. We relied on both classical
methods of synaptosome and PSD enrichment [27, 147] and a novel method
in which a crude synaptosome fraction was detergent solubilized and
separated by gel filtration. An anti-GFP antibody immobilized on magnetic
beads was used to affinity purify the tagged postsynaptic protein complex
[148, 149]. The specificity of the isolated protein complex was verified by
immunoblotting for known synaptic proteins (positive controls) and
contaminants (negative controls). Once the specificity of the approach was
confirmed, we relied on mass spectrometric analysis to identify the specific
postsynaptic protein components.

Identification of synaptic proteins by mass spectrometry
Mass spectrometric analysis was done in collaboration with members of the
Laboratory of Mass Spectrometry and Gaseous Ion Chemistry at The
Rockefeller University. Synaptic protein samples were separated by SDSPAGE and stained with MS compatible staining methods, such as
Coomassie blue or zinc staining. Individual protein bands were excised,

49

reduced, alkylated and digested with trypsin. The peptide mixtures were
analyzed by various MS techniques, such as single stage (e.g. MALDIQqToF or MALDI-ToF), multiple stage (e.g. MALDI or ESI-IT) mass
spectrometry, and on-line liquid chromatography tandem mass spectrometry
(LC-MS/MS) to generate peptide sequence information [150, 151]. Such an
approach has proved successful for analysis of the protein complex
associated with the glutamate receptor, N-methyl-D-aspartate (NMDA) [32].

Isolation of specific synapses for a comparative study
The value of such a novel approach for discovering determinants of
synaptic specificity lies in the fact that it enables the targeting of many
different synapse types. In order to decipher which proteins are functionally
important, it is crucial to make useful comparisons between different
synaptic populations.
One such comparison is between excitatory and inhibitory synapses in
the same cell type.

We expect there to be a considerable number of

distinguishing proteins between these two types of synapses since they are
functionally distinct, their receptors are genetically unrelated, they occupy
distinct cytochemical locations on the postsynaptic neuron and they arise
from distinct presynaptic cell types. To discover such differences one could

50

examine the protein profiles of AMPAR-containing and GABAR-containing
synapses in the same neurons (i.e. expressed under the same BAC control
elements). Any general determinants of inhibitory versus excitatory synapse
specificity should be found in several types of either excitatory or inhibitory
synapses, but not both. Furthermore, such an experiment would result in the
first successful biochemical purification of an inhibitory postsynaptic
specialization, and would provide important insights into the nature and
complexity of inhibitory synaptic structure.
Another interesting comparison is between excitatory synapses
themselves.

As summarized above, studies on AMPA receptor subunit

localization in the mammalian CNS have demonstrated striking differences
in the expression profiles of individual subunits. Inputs to the Purkinje cell
(PC) of the cerebellum exemplify synaptic specificity, since all excitatory
inputs to Purkinje cells contain the AMPA receptor GluR2 subunit, but only
the parallel fiber to Purkinje cell (PF/PC) synapses contain the GluRδ2
receptor. Purification of the PF/PC synapse would uncover the molecules
responsible for its unique structure and function.

Another example of

excitatory synaptic specificity lies in the laminar organization of AMPARs
in the cerebral cortex.

Pyramidal cells in the various cortical laminae

receive distinct afferents and express unique but overlapping AMPAR

51

subunits.

Furthermore, pyramidal cells within a given layer can be

subdivided into genetically and developmentally distinct populations. A
study to identify AMPAR interacting proteins specific to a given pyramidal
cell population is possible due to the availability of BAC transgenic lines
specific for pyramidal cell laminar expression (Figure 8). Purification and
identification of such molecules will expand our understanding of such cell
populations, and prove useful in defining CNS cell and synapse types.
We have successfully generated multiple BAC transgenic mouse
lines, each expressing a receptor-Venus fusion protein in a cell type of
interest. In addition, we have determined the technical limits of fusion
protein expression in the adult mammalian CNS. Using a novel approach to
study the postsynaptic specialization we have successfully purified both
excitatory and inhibitory synaptic protein complexes from distinct cell types.
A comprehensive analysis at the results of this work follows.
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CHAPTER II. MATERIALS AND METHODS
Animals
All experiments using animals were performed according to protocols
approved by the Institutional Animal Care and Use Committee at the
Rockefeller University.

All BAC transgenics were bred on the FVB

background and littermates were used as wild-type controls.

Antibodies
The following antibodies were used at the indicated dilutions:
rabbit anti-GFP, Abcam #ab6556 (1/5000 for immunoblotting; 1/500 for
immuno-electron microscopy); rabbit anti-GluRδ2, Millipore #AB1514
(1/2000); rabbit anti-GluR1, Abcam #ab31232 (1/1000); mouse anti-GluR2,
Millipore #MAB397 (1/500); mouse anti-PSD95, Affinity Bioreagents
#MA1-046 (1/2000); rabbit anti-PSD93 Millipore #AB5168 (1/100); mouse
anti-NR2A, Millipore #MAB5216 (1/500); mouse anti-Gephyrin, BD
transduction Laboratories #610584 (1/250); mouse anti-GABA(A) receptor
β2/3, Upstate #05-474 (1/1000); rabbit anti- GABA(A) receptor α1, Upstate
#06-868 (1/1000); rabbit anti- GABA(A) receptor α1, SantaCruz; rabbit
anti- GABA(A) receptor α6, Millipore #AB5610 (1/2500); rabbit antiGABA(A) receptor γ2, Millipore #AB6954 (1/1000); rabbit anti-Homer (H-
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342), Santa Cruz #sc-15321 (1/200); mouse anti-BiP/GRP78, BD
transduction Laboratories #610978 (1/500); mouse anti-COX (cytochrome
oxidase subunit I), Molecular Probes #A6403 (1/20000); rabbit antiRPTPmu, Abcam #ab23820; goat anti-BAIAP2, Abcam #ab15697; rabbit
anti-delta2 Catenin, Abcam # ab11352; rabbit anti-mGluR1, Abcam
#ab6439 (1/1000); guinea pig anti-VgluT1, Millipore (1/3000); guinea pig
anti-VgluT2,

Millipore

(1/3000);

mouse

anti-GAD65/67,

Stressgen

bioreagents #MSA-225 (1/500); rabbit anti-GAD65/67, Millipore #AB1511
(1/400); mouse anti-Gephyrin, BD trasnsduction Laboratories #610585
(1/1000); rabbit anti-Gephyrin, Millipore #AB5725 (1/1000); goat antiNeuroligin-2, Santa Cruz #sc-14089 (1/50); mouse anti-GRIP (1/500), BD
transduction laboratories #611318.

Rabbit anti-Neph1 was a generous gift from Pr. Sumant Chugh.

The polyclonal anti-Gm941 antiserum was custom-generated by injection
into rabbits of peptide #1, LKEGDEEIKSDIYTLC, and peptide#2,
PLKVERAPAPHGPC.
affinity-purified

against

Bleeds were purified using protein G and then
peptide

#2

Burlington).
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(Green

Mountain

Antibodies,

The polyclonal anti-MRCK gamma antibody was custom-generated by
injection into rabbits of the following peptide: SERPRSLPPDPESESSPC.
Bleeds were purified using protein G and then affinity-purified against the
peptide (Green Mountain Antibodies, Burlington).

The goat anti-GFP antiserum was generated by injection in a goat of the fulllength GFP (Green Mountain Antibodies) and was affinity-purified using a
column made of Sepharose-4B resin coupled to full-length GFP.

The monoclonal anti-EGFP antibody (clone 19F7) was generated by
immunizing mice with purified GST-EGFP fusion protein (Monoclonal
Antibody Core Facility at Memorial Sloan-Kettering Cancer Center, New
York). Several rounds of screening were performed to identify clones that
functioned well in immunoprecipitation assays.

Initially, monoclonal

supernatants were tested by ELISA using 96 well plates coated with EGFP
purified from transiently transfected 293T cells. Next, positive clones were
screened in immunoprecipitation assays, again using the EGFP purified from
transfected 293T cells. Finally, we identified four positive clones which
strongly immunoprecipitated EGFP from cerebellar lysates from a
transgenic mouse line expressing EGFP under the Pcp2 BAC driver.
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BAC modification and transgenic mice
Pcp2-VGluRδ2
The cDNA encoding GluRδ2 together with the 3’UTR was amplified from
cerebellar RNA, and placed in frame with a preprotrypsin signal sequence
and Venus in a building vector based on eGFP-C2 (Clontech, Mountain
View).

The sequence encoding the tagged VGluRδ2 and the SV40

polyadenylation signal from the building vector were subcloned into the
PL53.SC-AB shuttle vector. The Pcp2 containing BAC RP23-192G13 was
then modified by homologous recombination using this shuttle vector and
the two-step method [152]. Recombination boxes of 1kb were amplified
from the BAC genomic DNA using the following primers: for box A,
5’TTGGCGCGCCGGTTCCACCCTCATGTTG3’

AND

5’AGCTTTGTTTAAACCCGATCGCCCTGCACGTGGGG3’; for box B,
5’ATAAGAATGCGGCCGCCGGCTTTCTGGGTTCTGGC3’

and

5’ATAAGAATGCGGCCGCGTTTAAGCCAGGTGTGGG3’.

These

recombination boxes allow the replacement of the Pcp2 ATG by the cDNA
construct.

Correct modification of the Pcp2 BAC was visualized by

southern blot on BAC DNA digested by EcoRI, separated on 0.8% agarose
gel and probed with P32dATP-labeled box A.

Pulsed-field gel

electrophoresis was performed on BAC DNA digested by SpeI.
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Otx1-VGABAA Rα1 and Otx1-VGluR1
The cDNA encoding GABAA α1 or GluR1 together with the 3’UTR was
amplified from cortical RNA, and placed in frame with a preprotrypsin
signal sequence and Venus in a building vector based on eGFP-C2
(Clontech, Mountain View, USA).

The sequence encoding the tagged

VGABAA α1 or VGluR1 and the SV40 polyadenylation signal from the
building vector were subcloned into the PL53.SC-AB shuttle vector.
The Otx1 containing BAC RP23-106C14 was modified by homologous
recombination using this shuttle vector and the two-step method [152].
Recombination boxes of 1kb were amplified from the BAC genomic DNA
using

the

following

primers:

for

box

5’AGCTTTGTTTAAACGCTAACAGCCGGGTGGAGGT3’
5’TTGGCGCGCCGGCCTTCCAAAATCCCTAGA3’;

for

and
box

5’AAGGAAAAAAGCGGCCGCCTGAGGGGACATGCGAGA3’
5’CGACGCGTACCTCAAACAACCCCCATAC3’.

A,

B,
and

These recombination

boxes allow the replacement of the Otx1 ATG by the cDNA construct.

Additional BACs modified with VGluR1
Several additional BACs were modified with Venus-GluR1. The sequence
encoding VGluR1 and the SV40 polyadenylation signal from the eGFP-C2
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building vector were subcloned into the pLD53.SC2 shuttle vector. The
BAC was then modified by homologous recombination via a single 1kb box
following previously published methods [146]. Using this modified shuttle
vector it is not necessary to resolve the intervening sequences before
injecting the modified BAC into oocytes for generation of transgenic mice.
March4 (RP23-216L22)
Box A

5’AGCTTTGTTTAAACCCCTCCAAGCAGCAAATA3’
5’TTGGCGCGCCGTCTTCTACCCCCACCCAAT3’

Glt25d2 (RP23-160M1)
Box A

5’AGCTTTGTTTAAACGTTCCGTAGCCGGCGGGAGG3’
5’TTGGCGCGCCTGTGCTGATCTTCCCACTCT3’

Ntsr1 RP23-314D14
BoxA

5’GCATCGTCTCCAGTCCGAACTGTGGATGTGG3’
5’ CAGGTTGAACTGCTGATCAACAGATC3’

Drd4 RP23-134L4
BoxA

5’GATTCTGGCCCACGCCCGGCCAAC3’
5’CAGGTTGAACTGCTGATCAACAGATC3’

Correct modification of the each BAC was visualized by southern blot on
BAC DNA digested by EcoRI, separated on 0.8% agarose gel and probed
with P32dATP-labeled box A.
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A correctly modified BAC was purified by cesium chloride and DNA was
then dialyzed in oocyte injection buffer for generation of transgenic mice.
Integration of the BAC in the mouse genome was visualized by Southern
blot using genomic DNA digested by EcoRI and box A as a probe.

Preparation of synaptic protein complexes and affinity purification
Pcp2-VGluRδ2 and Pcp2-EGFP
Ten cerebella from adult mice were used for the preparation of a crude
synaptosome fraction P2 (based on previously published protocols [147]).
The solution used as a homogenization and resuspension buffer contained
0.32M sucrose, 5mM HEPES, 0.1mM EDTA, pH=7.3 and a protease
inhibitor cocktail (Sigma, Saint Louis). P2 was then solubilized 30 minutes
at 4°C using a final concentration of 0.5% Triton X-100.

The cleared

solubilized fraction was separated by gravity flow on a gel-filtration column
(Sephacryl S1000 Superfine, GE Healthcare) prepared using a solution
containing 2mM CaCl2, 132mM NaCl, 3mM KCl, 2mM MgSO4, 1.2 mM
NaH2PO4, 10mM HEPES and 0.5% Triton X-100, pH=7.4. 2 ml fractions
were collected and aliquots were used for protein dosage using the BCA
Protein assay kit (Pierce, Rockford). Calibration of the gel-filtration column
was performed using the gel filtration HMW calibration kit (GE Healthcare).
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Pooled fractions from the column were used for affinity-purification
of tagged PSDs.

Dynabeads M-270 epoxy beads (Dynal, Oslo) were

conjugated using 15 mg of affinity-purified goat anti-GFP antibody per mg
of beads [153]. 6 mg of beads were used for affinity-purification of pooled
synaptic fractions from 10 cerebella during one hour at 4°C. Beads were
then washed in 2mM CaCl2, 300mM NaCl, 3mM KCl, 2mM MgSO4, 1.2
mM NaH2PO4, 10mM HEPES and 0.5% Triton X-100. Purified complexes
were eluted in 0.5N NH4OH, 0.5mM EDTA for 20 minutes, dried and
resuspended in the desired volume of protein electrophoresis sample buffer.
Biochemical preparations and affinity-purifications were performed in
parallel for each genotype starting with 10 cerebella each.

For mass

spectrometry analysis, samples from several successive experiments were
pooled.

Otx1-VGABAARα1 and Otx1-GFP
Five cortices from adult mice were used for the preparation of a crude
synaptosome fraction P2 (based on previously published protocols [147].
The solution used as a homogenization and resuspension buffer contained
0.32M sucrose, 5mM HEPES, 0.1mM EDTA, pH=7.3 and a protease
inhibitor cocktail (Sigma, Saint Louis). P2 was then solubilized 30 minutes
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at 4°C using a final concentration of 0.1% Triton X-100.

The cleared

solubilized fraction was separated by gravity flow on a gel-filtration column
(Sephacryl S1000 Superfine, GE Healthcare) prepared using a solution
containing 2mM CaCl2, 132mM NaCl, 3mM KCl, 2mM MgSO4, 1.2 mM
NaH2PO4, 10mM HEPES and 0.1% Triton X-100, pH=7.4. 2 ml fractions
were collected and aliquots were used for protein dosage using the BCA
Protein assay kit (Pierce, Rockford). Calibration of the gel-filtration column
was performed using the gel filtration HMW calibration kit (GE Healthcare).
Pooled fractions from the column were used for affinity-purification
of tagged inhibitory synaptic protein complexes.

Dynabeads Protein G

beads (Dynal, Oslo) were conjugated in 0.15M KCl for 2 hours at room
temperature using 0.88 mg of mouse monoclonal anti-EGFP antibody per
1mL of beads. Following conjugation, the antibody was crosslinked to
ProteinG with 20mM Dimethyl pimelimidate•2 HCl (Pierce, Rockford, IL)
in 0.2 M triethanolamine, pH 8.0. The crosslinking reaction was stopped
with 50mM Tris pH 8.0. 5mL of beads were used for affinity-purification of
pooled synaptic fractions from 5 cortices during forty-five minutes at 4°C.
Beads were then washed in 2mM CaCl2, 300mM NaCl, 3mM KCl, 2mM
MgSO4, 1.2mM NaH2PO4, 10mM HEPES and 0.1% Triton X-100. Purified
complexes were finally eluted in 1.0N NH4OH, 0.5mM EDTA for 20
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minutes, dried and resuspended in the desired volume of protein
electrophoresis sample buffer.

Biochemical preparations and affinity-

purifications were performed in parallel for each genotype starting with 5
cortices each.

For mass spectrometry analysis, samples from several

successive experiments were pooled.

Otx1-VGluR1 and p338-VGluR1
Between three and five cortices or ten hippocampi from adult mice were
subject to biochemical purification of PSDs as described above for Pcp2VGluRδ2, the only difference was that the final concentration of Triton X100 was 1.0%. for cortex and 0.1% for hippocampus. This percentage
Triton X-100 was used for solubilization of the crude synaptosome fraction
and in the gel filtration buffer. Pooled fractions from the column were used
for affinity purification as described above for Otx1-VGABAA α1.

Protein extracts for expression analysis
Total protein extracts from cerebellum, hippocampus or cerebral cortex were
prepared by homogenizing the tissue and incubating for 30 minutes at 4°C in
a buffer containing 50 mM Tris-Cl, 150mM NaCl, 0.1% SDS, 0.5% sodium
deoxycholate and 1% NP-40 complemented with a protease inhibitor
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cocktail. The homogenate was then sonicated and centrifuged 30 minutes at
maximum speed to provide the supernatant for western blot analysis.
For immunoprecipitation experiments, the homogenate was incubated in 50
mM Tris-Cl, pH=7.4, containing 1% Triton X-100 final for 30 minutes and
then centrifuged at maximum speed. The supernatant was affinity-purified
using anti-GFP coated dynabeads for one hour at 4°C. Beads were washed
with 50 mM Tris-Cl, pH=7.4, containing 1% Triton X-100 and
immunocomplexes eluted for western blot analysis.

Immunoblotting
Protein samples (dissolved in NuPAGE LDS sample buffer, Invitrogen,
Carlsbad) were separated on 4-12% NuPAGE Bis-Tris gels (Invitrogen).
Proteins were then transferred using the semi-dry method (SD transfer cell,
Biorad, Hercules) on Immobilon-P PVDF membrane (Millipore, Bedford).
Antibodies were diluted in 5% milk/PBS/0.2% Tween-20.

Secondary

antibodies were conjugated to horseradish peroxidase (Pierce) and detection
performed using a chemoluminescent substrate.
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Immunofluorescence
Mice were perfused transcardiacally using 4% paraformaldehyde in
phosphate buffer saline pH=7.4 (PBS), then 10% sucrose in PBS. Brains
were incubated for 3 days in 30% sucrose in PBS. 25 mm-thick cerebellar
or whole brain saggittal sections were cut using a freezing sliding
microtome.
For detection of VGluRδ2 or VGluR1, sections were incubated in
0.3% H2O2 in PBS at 4°C, washed in PBS and preincubated in 4% normal
donkey serum in PBS. Incubation with the goat anti-GFP antibody (diluted
1/25000 in 1% normal donkey serum/PBS/1% Triton X-100/0.1%fish
gelatin) was performed overnight at 4°C. Immunolabeling was detected
using a biotinylated anti-goat secondary antibody (1/5000 in PBS/1% Triton
X-100/0.1% fish gelatin) followed by amplification using streptavidin-HRP
(1/500) and TSA-FITC (Perkin Elmer, Waltham, USA). All washes were
performed in PBS/1% Triton X-100.
For detection of the other antigens by immunofluorescence, sections
were incubated overnight with the corresponding antibodies and mouse anticalbindin (1/5000, Swant, Bellinzona) diluted in 1.0% normal donkey
serum/PBS/0.2% Triton X-100.

Immunolabeling was detected using an

Alexa-488 conjugated anti-rabbit or anti-goat and a Rhodamine-RedX
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conjugated anti-mouse or Cy3 conjugated anti-guinea pig. All washes were
performed in PBS/0.2% Triton X-100. Pictures were taken using a LSM
510 laser scanning confocal microscope (Carl Zeiss, Thornwood, USA).

Immuno-electron microscopy of Otx1-VGABAARα 1
Preparation of brain tissue for light and electron microscopy
Transcardial perfusion was achieved by using a peristaltic pump to control
the flow-rate of the perfusates to 10 ml/min.

The perfusates were the

following: (1) 10 - 50 ml of saline containing heparin (1000 U/ml), over a 1min period; (2) 200 ml of 0.1 % glutaraldehyde, mixed with 4.0%
paraformaldehyde in 0.1M phosphate buffer (pH 7.4).

During the

subsequent hours, the brain was cut into 40 mm-thick sections using a
vibratome.

On the 5th hour following the perfusion, the sections were

immersed in PBS containing 1.0% sodium borohydride, so as to terminate
residual cross-linking activities of glutaraldehyde.

GAD65/67 and GFP Double Immunocytochemistry
Double labeling using 3,3-diaminobenzidine HCl (DAB) and silverintensified colloidal gold (SIG) immunolabeling techniques were employed
to mark the colocalization of Venus-GABAA α1 and GAD 65/67 [154].
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Cortical sections were incubated for 30 min in PBS-azide containing 1%
bovine serum albumin (BSA) (Sigma Chemicals, Saint Louis) to block any
nonspecific immunolabeling.

These sections were then incubated on a

shaker for 3 days at room temperature in PBS-BSA-azide containing
primary antibodies, goat anti-GFP (1:500) to recognize Venus-GABAA α1,
and rabbit anti-GAD65/67 (1:400). This and all subsequent incubation steps
were followed by 3 rinses in PBS (pH 7.4).
For immunolabeling with DAB, sections were incubated in biotinylated
rabbit anti-goat IgG, recognizing the anti-GFP antibody, or in goat antirabbit IgG, recognizing the anti-GAD antibody (Vector Laboratories,
Burlingame), both at dilutions of 1:100 (15 mg/ml) for 1 hour at room
temperature. Sections were then incubated in the ABC solution (Elite Kit,
Vector Laboratories, Burlingame) for 30 min and immersed in PBS (pH 7.4)
containing 0.3% DAB with 0.03% hydrogen peroxide (H2O2) . Reaction
time was approximately 10 minutes for all sections. The peroxidase reaction
was terminated by immersing sections in PBS.

This ICC reaction was

followed by multiple postfixation steps to preserve ultrastructure: 1.0%
glutaraldehyde with PBS (pH 7.4) for 10 min; 0.1% osmium tetroxide (in
0.1 M PB) for 30 minutes; and 1.0% uranyl acetate in 70% ethanol,
overnight.
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For Venus-GABAARα1 immunolabeling with SIG, sections were
incubated for 16 hour in ultrasmall (0.8 nm) gold-conjugated rabbit anti-goat
IgG (Electron Microscopy Sciences, Washington) at a dilution of 1:100 in
PBS--BSA (pH 7.6). Sections were then postfixed in 1.0% glutaraldehyde
with PBS (pH 7.4) for 10 min to cross-link antibodies to antigenic sites prior
to silver intensification.

To prepare sections for silver intensification,

sections were rinsed for 1 min in 0.2 M citrate buffer (pH 7.4). These
sections were immersed into the silver intensification reagent (Silver
IntensEM Kit, Amersham, Buckinghamshire) at room temperature for 12
min. The duration of the silver intensification step differed by no more than
10 s among the samples. Silver intensification was terminated by rinsing
sections in citrate buffer. These sections were stored in PBS overnight. On
the following day, sections were incubated in 0.1% osmium tetroxide (in 0.1
M PB) for 30 minutes; and 1.0% uranyl acetate in 70% ethanol, overnight.

Images used for were captured digitally using a CCD camera attached to a
JEOL 1200XL electron microscope at a magnification of 40,000-60,000x
and spanning and area of 29 mm2.
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Mass spectrometry analysis
Pcp2-VGluRδ2 and Pcp2-EGFP
Following immunopurifications, the isolated proteins were resolved by 1-D
SDS-PAGE and stained with Coomassie Blue (GelCode Blue, Pierce). Each
entire gel lane (from the 30 and 50 mice preparations) was cut into 1mm
sections, and proteins were digested with 12.5ng/μL sequencing grade
modified trypsin (Promega, WI, USA).

The resulting peptides were

extracted on reverse phase resin (Poros 20 R2, PerSeptive Biosystems),
eluted with 50% (v/v) methanol, 20% (v/v) acetonitrile and 0.1% (v/v)
trifluoroacetic acid, and subjected to MALDI QqTOF MS and MALDI ion
trap MS/MS analyses as described [155, 156].

Otx1-VGABAA α1 and Otx1-EGFP
Following immunopurifications, the isolated proteins were subject to
analysis by LC-MS/MS based on previously published protocols [157].
Immunopurified proteins were resolved by 1-dimensional SDS-PAGE and
stained with E-ZincTM Reversible Stain Kit (Thermo Scientific, Rockford,
IL). Each gel lane was divided into two sub-samples. One sub-sample
contained all visible gel bands, and the other contained the gel regions
between the bands. Proteins in each sub-sample were subjected to in-gel

68

digestion by incubating with Trypsin (Roche, Indianapolis). The resulting
peptides were extracted onto POROS 20 beads (20 um C18 particles)
(Applied Biosystem, Foster City). For liquid chromatography-tandem mass
spectrometry analysis, peptides were eluted and loaded onto a 360 µm o.d. x
75 µm i.d. analytical column (6 cm long) packed with C18 5 µm sized resin
(YMC Co., Kyoto) constructed with an integrated electrospray emitter tip
(New Objective, Woburn). Peptides were then eluted from the analytical
column directly into a LTQ-Orbitrap mass spectrometer (Thermo Scientific,
Waltham) using a HPLC solvent delivery system at a flow rate of 300nl/min.
The acquired LC-MS/MS data were used to identify proteins present
in each sub-sample by searching a mouse protein sequence database using
the GPM database search program(http://prowl.rockefeller.edu
/tandem/thegpm_tandem.html). Mass tolerances used in the database
searching were 15 ppm and 0.4 Da, respectively, for measured masses of
peptide ions and for fragmentation ions. The cut-off score (the logarithm of
E-value) of -4 is used for identified proteins.

Combining two lists of

proteins from the two sub-samples of each IP sample, we generated a list of
proteins present in the IP sample. To obtain proteins uniquely present in the
fusion protein IP sample, we subtracted proteins found in control IP sample
from the list of proteins found in the fusion protein IP sample.
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CHAPTER III. PROTEIN PROFILE OF THE PARALLEL FIBERPURKINJE CELL SYNAPSE
Introduction
The Purkinje cell (PC) is the major output neuron of the cerebellum, and its
function is crucial for motor development and learning [56, 158]. The major
excitatory afferents to PCs are from the granule cell (GC) axons, as they
branch to form the parallel fibers (PFs), and from the climbing fibers (CFs),
whose axons originate from the inferior olive. Purkinje cells selectively
express GluRδ2, a glutamate receptor subtype. Although GluRδ2 protein is
initially found at spines at CF/PC and PF/PC synapses, it localizes to PF/PC
synapses after approximately P21 [65]. Because PFs form synapses on
distal dendrites of Purkinje cells, a unique sorting mechanism must be
necessary for GluRδ2 to bypass CF synapses, which are located at proximal
dendrites. The mechanism of such a sorting mechanism remains unknown,
as it has not previously been possible to molecularly dissect the two synapse
types.
Dysfunction of the cerebellum typically manifests as motor
discoordination, or ataxia, a common symptom of various neurological
disorders in mice and humans. Recent studies have also demonstrated the
involvement

of

the

cerebellum

in
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non-motor

functions

and

in

neuropsychiatric disorders such as dyslexia, autism, and attention deficit
hyperactivity disorder [159-161]. The lack of specific pharmacological tools
with which to manipulate GluRδ2 has hampered studies to determine its
function. However, studies of mutant mice, such as GluRδ2−/− and hotfoot,
in which the receptor fails to traffic to the PC surface, have provided some
clues to the function of GluRδ2 in Purkinje cells.

Ataxia is easily

recognized as the phenotype of these mutations, but it is not accompanied by
a macroscopic morphological anomaly in the cerebellum [66]. LTD of
Purkinje cells from these mice is impaired in vitro, and they perform poorly
on tasks that measure behavioral plasticity [161, 162].
The factor(s) that activates GluRδ2 receptors, a ligand, a receptor
subunit or associated messengers have yet to be found.

A better

understanding of GluRδ2 function may provide key insights into normal and
abnormal cerebellar functions and thus permit the development of novel
approaches for therapy of particular neurological disorders. To this end we
targeted the parallel fiber-Purkinje cell (PF/PC) synapse for affinity
purification and protein analysis by mass spectrometry using our novel
approach.
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Results
Generation of mice with tagged parallel fiber – Purkinje cell synapses
In order to specifically purify PF/PC synapses, we used molecular cloning to
generate a synaptic tag consisting of GluRδ2 fused to an N-terminal affinity
tag, Venus (a YFP variant).

This fusion protein was tested for proper

expression and trafficking to cell surface in transfected HEK293 cells
(Figure 9A).

Immunoblot analysis of protein extract obtained from

transfected HEK293 cells shows that an anti-GluRδ2 antibody recognizes
the fusion protein at the expected size, approximately 140 kDa, and that it is
absent from cells transfected with Venus alone.

The GluRδ2 antibody

recognizes the wild-type protein in cerebellar protein extract at a size smaller
than the fusion protein by the expected 27 kDa. Immunocytochemistry
using an anti-GFP antibody shows surface expression of the Venus-GluRδ2
(VGluRδ2) fusion protein in transfected HEK293 cells under nonpermeabilizing conditions, with the N-terminal Venus was localized
extracellularly.
In order to express VGluRδ2 selectively in Purkinje cells of the
cerebellum we relied on the BAC transgenic approach [6]. Homologous
recombination was used to insert the transgene cDNA into the Pcp2 BAC
[5], which contains the regulatory sequences for Purkinje
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Figure 9. Construction of a fusion between Venus and GluRδ2
(VGluRδ2). (A) Venus was fused on the N-terminal extracellular part of
GluRδ2 (top left panel). A GluRδ2 positive band was detected in protein
extracts from VGluRδ2 transfected HEK293 cells, but not in extracts
from Venus-transfected cells (bottom left panel). The band was at the
expected size (about 140 kDa), larger than the endogenous GluRδ2
detected in cerebellar extracts. Immunofluorescence using an anti-GFP
antibody detected the extracellular Venus in VGluRδ2 transfected cells in
non-permeabilizing conditions (red, right panels), showing the proper
topography of the tagged receptor. (B) The correct modification of the
Pcp2 BAC with the VGluRδ2 construct was checked by Southern blot
(left panel, probe shown in C, BAC DNA digested with EcoRI) and
pulsed-field gel electrophoresis (right panel, BAC DNA digested with
SpeI), before injection in mouse oocytes. (C) Schematic diagram of the
BAC containing the Pcp2 gene, which is expressed specifically in
Purkinje cells. The VGluRδ2 cDNA was placed at the level of the Pcp2
ATG. The arrow indicates the regulatory region. Scale bar = 0.5 Kb.
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Figure 9. Construction of a fusion between Venus and GluRδ2
(VGluRδ2).
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cell specific expression (Figure 9C).

Pulsed-field gel electrophoresis

(PFGE) and Southern blotting (Figure 9B, left panel) were used to verify
correct modification of the Pcp2 BAC. The VGluRδ2 cDNA was placed at
the level of the Pcp2 ATG, to disrupt expression of the endogenous BAC
Pcp2 protein (Figure 9C).
We next generated transgenic mice containing the Pcp2-VGluRδ2
construct, by surgical implantation of injected fertilized oocytes into a
pseudopregnant female. PCR screening and Southern blot analysis was used
to determine both the presence and copy number of transgene insertion into
the genome (Figure 10A). The VGluRδ2 construct contains an additional
EcoR1 restriction site, which enables the probe to distinguish the wild-type
Pcp2 sequence from that contained within the BAC transgene. Using this
probe against whole genome DNA digested with EcoR1 reveals a second
band present only in the transgenic mice that corresponds to the Pcp2VGluRδ2 transgene.
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Figure 10. Tagging the parallel fiber/ Purkinje cell synapse in
transgenic mice. (A) Southern blot was used to identify transgenic mice
having integrated the Pcp2 BAC containing VGluRδ2. (B) VGluRδ2
expression was detected using an anti-GFP antibody that recognizes
Venus, on immunoblots from total protein extracts of transgenic (Tg)
versus wild-type (Wt) cerebella. * indicates a non-specific band. (C) Both
VGluRδ2 and GFP were affinity-purified using a goat anti-GFP antibody
from 1.0% Triton X-100 cerebellar extracts from wild-type (Wt),
Pcp2/VGluRδ2 (Vδ2) and Pcp2/EGFP control (GFP) mice, as shown by
probing the immunoblots with an anti-GFP antibody (left). VGluRδ2
specifically copurified the endogenous GluRδ2, as shown by probing the
same blot with an anti-GluRδ2 antibody (right). (D) Immunofluorescence
on cerebellar sections using an anti-GFP antibody shows the specific
localization of VGluRδ2 in the molecular layer (ml) and somata of
Purkinje cells (Pcl) of Pcp2/VGluRδ2 mice. Soluble GFP is detected in
the molecular layer, dendrites, somata and axons of Purkinje cells in
sections from Pcp2/EGFP mice. Abbreviations: ml, molecular layer; Pcl,
purkinje cell layer; gcl, granule cell layer. Scale bars: upper panels= 200
µm; lower panels= 50 µm.

76

Figure 10. Tagging the parallel fiber to Purkinje cell synapse in
transgenic mice.

To confirm expression of the VGluRδ2 transgene, we collected cerebellar
protein extract from both wild-type and Pcp2-VGluRδ2 transgenic mice.
SDS-PAGE followed by immunoblotting with anti-GFP antibody revealed
the presence of the fusion protein at the expected size only in the transgenic
mouse (Figure 10B). The VGluRδ2 fusion protein was successfully affinity
purified from cerebellar protein extract using a goat anti-GFP antibody
(Figure 10C). SDS-PAGE followed by immunoblotting with an anti-GFP
antibody of the affinity-purified material from Pcp2/VGluRδ2 mice showed
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the fusion protein present at the correct size. This band was absent from
material purified from wild-type mice.

In addition, we used a mouse

expressing soluble GFP in Purkinje cells under the same Pcp2 BAC as a
positive control for the affinity purification conditions.

The band

corresponding to VGluRδ2 is absent, while the soluble GFP band is present
at the expected size. Immunoblotting of this same material with an antiGluRδ2 antibody reveals both the VGluRδ2 fusion protein and the wild-type
GluRδ2 protein, demonstrating their successful oligomerization. Neither
GluRδ2 nor VGluRδ2 co-purified from the wild-type or Pcp2-GFP extract,
demonstrating the specificity of the affinity purification method (Figure
10C, right).
confirmed

Immunohistochemistry on fixed cerebellar brain tissue
correct

expression

and

localization

of

VGluRδ2

in

Pcp2/VGluRδ2 mice (Figure 10D). Immunofluoresence using an anti-GFP
antibody shows the expected localization of VGluRδ2 in the molecular layer
and somata of Purkinje cells. The expression pattern in Pcp2/VGluRδ2
shows soluble GFP present in all layers of the cerebellum, including
Purkinje cell dendrites and axons (Figure 10D, right).
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Biochemical purification of tagged parallel fiber – Purkinje cell synapses
In order to verify the presence of VGluRδ2 in the synaptic fraction from
cerebellar extract, we used a previously published synaptosome enrichment
method, which relies on centrifugation of homogenized cerebellar material
through a discontinuous Percoll gradient [147]. The synaptosome fraction
was enriched in endogenous synaptic proteins such as GluRδ2,
GABAAR α1, and PSD95 (Figure 11, left panel), while BIP, an endoplasmic
reticulum marker, and COX, a mitochondrial marker, were selectively
absent. VGluRδ2 was detected in the synaptosome-enriched fraction and
was distributed amongst the different fractions in the same manner as wildtype GluRδ2.

Finally, electron microscopy of the synaptic fraction (3)

showed enrichment for synaptosomes.
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Figure 11. Synaptosome preparation from VGluRδ2 cerebella using
the Percoll gradient method. Fractions were probed for excitatory
synapse markers (GRID2, PSD95), the inhibitory synapse marker
GABA(A)Ra1, the endoplasmic reticulum marker BIP and the
mitochondrial marker COX. VGluRδ2 was detected using an anti-GFP
antibody. The right panel shows an electron micrograph from fraction 3
enriched in synaptosomes.

Using the classical purification approach we successfully isolated the tagged
parallel fiber to Purkinje cell synapse. However, the material losses from
this method were substantial. In order to more efficiently enrich for the
postsynaptic density (PSD) we developed a novel method based on
solubilization of a crude synaptosome fraction followed by size exclusion
chromatography to enrich for the PSD protein complex (Figure 12).
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Figure 12. VGluRδ2 is detected in excitatory synaptic fractions
using a new purification method. (A) We prepared a crude
synaptosome P2 fraction that was solubilized in 0.5% Triton X-100.
The extract was then separated on a Sephacryl S1000 gel filtration
column. Calibration of the column indicated that protein complexes
smaller than 669 kDa (arrow in B) were resolved after fraction 10.
(B) Protein concentration was measured for every fraction collected.
(C) 0.1% in volume of every fraction was assayed for the presence of
excitatory synapse markers (GluRδ2, GLUR2, PSD95, NR2A),
inhibitory synapse markers (GABA(A)Rβ, GABA(A)Rα1), the
endoplasmic reticulum marker, BIP and the mitochondrial marker,
COX. VGluRδ2 was detected using an anti-GFP antibody. The red
rectangle outlines the “excitatory synaptic” fractions enriched for
synaptic markers and pooled for subsequent affinity-purification of
PF/PC PSDs.

81

A

B

Homogenize, H

0.9

1500 g,
10 min

S1

P1
Rehomogenize
1500 g,
10 min

P1'

Protein (mg/ml)

0.8

12000 g,
20 min

S1'

S2

P2
0.5% Triton X100
3000 g,
20 min

P3

C

0.7
0.6
0.5
0.4
0.3
0.2

669 kDa

0.1

0

S3

collect
fractions

S1
+
H P1’ S1’ P2 S2 P3 S3

-0.1

5

S3

5

6

6

7

7

8

8

9

10

11

Fractions

12

13

14

9 10 11 12 13 14

VGluR"2
GluR"2
GluR2
PSD95
NR2A
GABA(A)R!
GABA(A)R#1
BiP
COX

Synapsin I
Synaptophysin

Fig. 2
Selimi etin
al. excitatory synaptic fractions using a
Figure 12. VGluRδ2 is detected

new purification method.

82

Homogenization of the cerebella from 10 mice was followed by differential
centrifugation to enrich for synaptosomes (Figure 12A). This fraction, P2,
was solubilized with Triton X-100 at a final concentration of 0.5% to isolate
the large, detergent-insoluble protein complexes, including the PSD. To
determine the relative enrichment of synaptic and non-synaptic proteins,
each fraction was analyzed by SDS-PAGE and immunoblotting (Figure
12C).

The solubilized crude synaptosome fraction (S3) is enriched for

synaptic proteins such as neurotransmitter receptors (GluR2, GluRδ2,
NR2A, GABAARβ2, GABAARα1), scaffolding proteins (PSD95), and
presynaptic markers (synapsin I, synaptophysin). In addition, VGluRδ2 was
enriched in S3 like wild-type GluRδ2, suggesting correct trafficking of the
fusion protein to the postsynaptic specialization.
Next, the solubilized extract, S3, was fractionated using a Sephacryl
S1000 gel filtration column (Figure 12C, right). In this way we were able to
separate large protein complexes (>669 kDa), which elute in the early
fractions and likely correspond to the PSD, from those that elute later and
are at a size consistent with intracellular protein complexes.

Protein

concentration was measured for each fraction eluted from the column
(Figure 12B).

Excitatory PSD proteins were selectively enriched in

fractions 6-9 (Figure 12C, red triangle), as shown by the distribution of
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GluRδ2, GluR2, NR2A and PSD95, as well as the fusion protein, VGluRδ2.
On the other hand, inhibitory postsynaptic proteins (GABAARβ2,
GABAARα1), presynaptic elements (synapsin I, synaptophysin), and
endoplasmic reticulum (ER) marker (BIP) eluted later in the column and
were largely excluded from the early, synaptic fractions. In this way we
successfully isolated a sample that is selectively enriched for excitatory
PSDs from cerebellum.
This pool of PSDs was next subject to affinity purification using a
goat anti-GFP antibody, to isolate the tagged parallel fiber to Purkinje cell
synapses (Figure 13). Co-immunopurified proteins were collected from the
excitatory synaptic fractions of both Pcp2-VGlurδ2 mice and Pcp2-GFP
mice, which served as a positive control for affinity purification conditions,
and a negative control for co-immunopurification of synaptic proteins.
Immunoblot analysis of the purified materials using an anti-GFP antibody
indicated successful precipitation of the VGluRδ2 fusion protein or soluble
GFP (Figure 13A).
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Figure 13. Affinity-purification and protein profiling of the parallel
fiber/Purkinje cell PSDs. (A) Synaptic fractions from Pcp2/VGluRδ2
animals were affinity-purified using magnetic beads coated with anti-GFP
antibody (VGluRδ2). In parallel, control purifications were performed on
preparations from Pcp2/eGFP transgenic mice (GFP). 0.025% of the
inputs and flow-throughs (FT) and 25% of the affinity-purified samples
(IP) were assayed by Western blot using an anti-GFP antibody and
showed immunoprecipitation of both VGluRδ2 and GFP, respectively.
(B) The same blot was probed for different synaptic markers and the
mitochondrial protein COX, showing specific co-purification of synaptic
markers localized to the PF/PC synapse. (C) Electron microscopy electron
dense structures reminiscent of PSDs on the surface of the magnetic beads
used for affinity-purification of Pcp2/VGluRδ2 extracts. (D) Proteins
from the affinity-purified VGluRδ2 PSDs were separated by SDS-PAGE
and stained with Coomassie Blue before mass spectrometry analysis. (E)
Mass spectrometry identified 65 different proteins in the complexes
purified from Pcp2/VGluRδ2 mice. These proteins could be classified
into 11 functional categories. The number of proteins from each category
is indicated in parenthesis.
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Analysis by western blot demonstrated the co-immunopurification of several
positive makers of the PF/PC synapse (GluRδ2, Homer, PSD93, GluR2/3,
and PSD95) as well as the absence of inhibitory synaptic markers
(GABAARα6, GABAARβ, gephyrin), presynaptic markers (synapsin I,
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synaptophysin) and the mitochondrial marker (COX) (Figure 13B). These
results demonstrate the robust and specific isolation of the tagged parallel
fiber to Purkinje cell synapse. Furthermore, electron microscopy of the
magnetic beads used for affinity purification showed the presence of
electron dense structures resembling the PSD in both structure and size
(Figure 13C).

Mass spectrometry of the parallel fiber-Purkinje cell synapse
Mass spectrometry (MS) was used to identify the proteins purified from both
Pcp2-VGluRδ2 and Pcp2-GFP. The material from several experiments was
pooled (30 or 50 cerebella), separated by SDS-PAGE (Figure 13D) and
analyzed by MALDI-TOF MS/MS. A total of 65 proteins were identified:
37 proteins were detected with high confidence (Table 3), and 28 were
observed at lower levels and identified with less confidence (Table 4).
Proteins known to be present at the PF/PC synapse and found by
immunoblot analysis to co-purify with VGluRδ2 were confirmed by the MS
results. These include the wild-type GluRδ2, AMPAR subunit GluR2 and
the scaffolding proteins PSD95, PSD93 and Homer3. Additionally we were
able to confirm the absence of presynaptic components and inhibitory
neurotransmitter receptors and scaffolding molecules.
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Also absent were

components of distinct excitatory PSDs, such as NMDA receptor subunits.
Finally, we identified several additional scaffolding molecules previously
shown to colocalize with GluRδ2, including Shank1 and Shank2, delphilin,
and GluRδ2-interacting protein (Grid2ip).
The proteins we identified specifically at the PF/PC synapse could be
grouped into eleven functional categories (Figure 13D; Tables 3 and 4).
Several of the known markers for the PF/PC PSD were grouped as
“scaffolds and adapters”, including several members of the Shank family
and the PSD family. Other functional categories include proteins important
for synapse formation and physiology, like regulators of small GTPases and
protein kinases. In addition to proteins of expected functional relevance,
eight of the proteins identified in our study can regulate or be regulated by
phospholipid metabolism (Itpr1, synaptojanin 1 and 2, phospholipase B,
ABCA12, MRCKγ), or contain phospholipid-binding domains (Plekha7,
annexin A6, MRCKγ). Proteins in this group were previously unrecognized
components of the PF/PC PSD and were thus grouped into a novel category,
“phospholipid metabolism and signaling”. There is evidence to support the
role of phospholipid regulation at this synapse, based on the known role of
the metabotropic glutatmate receptor 1 (mGluR1) in regulating LTD through
activation of phospholipase C [67]. Another important category of PSD
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proteins contained receptors and ion channels, including glutamate receptor
subunits and several G protein-coupled receptors (GABA-B and BAI
receptors). The BAI receptor, a G protein-coupled receptor, is likely to
mediate cell adhesion [163]. Several other proteins identified at the PF/PC
synapse in our study are involved in cell adhesion and interaction with the
extracellular matrix: receptor protein tyrosine phosphatases [164], deltacatenin-2 [165], and Neph1 [142].

The functional diversity of proteins

present at the parallel fiber to Purkinje cell synapse may underlie the need
for a multitude of molecules in specifying this synapse.
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Table 3. List of proteins identified in the immunoisolates of Venustagged GluRδ2. Results are shown of two replicate experiments from
either 30 or 50 mice. The detection and confirmation of the proteins
through MS and MS/MS analyses are indicated for both experiments.
The number of peptides confirmed by MS/MS analysis is shown for
each protein. The presence of these proteins in the control experiment,
as judged by hypothesis-driven MS/MS analyses, is indicated. Where
the presence or absence of the protein could not be judged
conclusively, due either to depletion of sample or to inconclusive
fragmentation, the entry is marked as not available (n/a).
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Table 4. List of proteins identified in the immunoisolates of Venustagged GluRδ2 with lower levels of confidence as judged by mass
spectrometry. Results are shown from two replicate experiments from
either 30 or 50 mice. The detection and confirmation of the proteins
through MS and MS/MS analyses is indicated for both experiments.
The number of peptides confirmed by MS/MS analyses is shown for
each protein. Several proteins were not observed (n/o) at the MS
analysis stage, but were identified from MS/MS analyses. The
presence of these proteins in the control experiment, as judged by
hypothesis-driven MS/MS analyses, is indicated. Where due to either
depletion of sample or inconclusive fragmentation, the presence or
absence of the protein could not be judged conclusively, the entry is
marked as not available (n/a)
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Confirmation of candidate proteins
To provide additional evidence for the synaptic localization of the
novel

components

that

we

have

identified,

we

performed

immunofluorescence studies on cerebellar sections from wild-type mice.
Localization in the molecular layer of the cerebellum, which contains the
PF/PC synapses, was evident for MRCKγ, Gm941, BAIAP2, RPTPm,
Neph1, and delta2-catenin (Figure 14). Delta2-catenin and Gm941 could
also be detected in some cerebellar interneurons. Examination of several in
situ hybridization databases (www.stjudebgem.org; www.brain-map.org;
www.genepaint.org) was used to confirm the expression pattern of candidate
proteins. Interpretable data were available for 42 candidates, and all but two
were expressed in Purkinje cells, with a majority showing little detectable
expression in the granule cell layer (data not shown). These expression data
provide additional confirmation that the majority of the proteins identified in
our study are components of the PF/PC synapse.
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Figure 14. Localization of novel components of PF/PC synapse.
(A) Presence of selected candidates in PF/PC PSDs purified from
Pcp2/VGluRδ2 cerebella. 0.025% of the inputs and flow-throughs (FT)
and 25% of the affinity-purified samples (IP) obtained from Pcp2-GFP
control (GFP) and Pcp2-VGluRδ2 (VGluRδ2) cerebella were assayed by
western

blot.

(B)

Immunofluorescence

Analysis
labeling

of

candidate

synaptic

was

performed

using

proteins.
antibodies

recognizing several candidate proteins identified by mass spectrometry
(green) in conjunction with an anti-calbindin antibody specifically
labeling Purkinje cells (red). Scale bars: 50 mm.
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Summary
We have successfully targeted expression of a Venus-GluRδ2 fusion
protein to the parallel fiber-Purkinje cell synapse of the cerebellum using the
BAC transgenic approach. The fusion protein displays correct topography in
heterologous cells and is present in classically purified synaptic fractions
from mouse cerebellum. Purification of the tagged PF/PC synapses was
achieved with a novel biochemical method that relies on solubilization of a
crude synaptosome fraction followed by gel filtration to enrich for PSDs.
The tagged PF/PC synaptic complex was affinity purified from this PSD
fraction and analyzed by mass spectrometry.

Using this approach we

identified approximately 65 proteins, including a novel group of
“phospholipid metabolism and signaling” proteins, which are previously
unrecognized components of this synapse.
Among the proteins identified were several that represent novel
members of this synapse, such as GPM741, RPTPm and BAIAP2. Using
immunohistochemistry and immunoblotting we confirmed the Purkinje cell
specificity of several candidate proteins identified by mass spectrometry.
This work represents the first successful purification of an individual
synapse type, and demonstrates the strength of such a strategy in uncovering
novel functional components of a particular synapse type.
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CHAPTER IV. EXPRESSION OF AN AMPA RECEPTOR FUSION
PROTEIN IN CORTICAL PYRAMIDAL NEURONS
Introduction
A study of synaptic specificity, and the potential for uncovering a “synaptic
code,” is facilitated by the ability to tag and purify multiple synapse types
for a comparative study.

The GENSAT project has facilitated such an

approach, in that we can quickly generate multiple lines of transgenic mice
each expressing a synaptic tag in a distinct cell population. We have taken
advantage of this in designing a study of AMPA receptor subunit GluR1
containing excitatory synapse types across distinct laminae of the cerebral
cortex.
The distribution of AMPA receptor subunits varies across cortical
laminae, but the GluR1 subunit is present abundantly in all pyramidal
neurons. A comparison of excitatory synaptic protein complexes would
validate the known subunit expression patters as well as expand the protein
profile of these synapses to include additional molecules important for
laminar specificity of excitatory inputs. In addition, it is possible to discover
tissue specific markers of excitatory synapses by comparison of GluR1containing cortical synapses to the GluRδ2-containing Purkinje cell
synapses we have previously analyzed.
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Results
Cloning and expression of a Venus-GluR1 fusion protein
In order to tag and purify excitatory synapses, we designed a GluR1 fusion
protein with an affinity tag, Venus, located extracellularly at the N-terminus
(Figure 15A). This fusion protein has proved useful in studying AMPA
receptor trafficking and protein interactions in a multitude of experiments
both in cultured neurons and in vivo [84, 86, 88]. We confirmed expression
and membrane trafficking of the Venus-GluR1 fusion protein (VGluR1) in
HEK293 cells.

Transfected cells were processed for immunochemistry

under non-permeabilizing conditions using an anti-GFP antibody, which
showed Venus localized extracellularly (data not shown).
We next generated transgenic mice that express the Venus-GluR1
fusion protein under Otx1 gene regulatory elements, using the Otx1 BAC
(Figure 15D).

This BAC has been shown to drive expression in a

subpopulations of cortical layer V pyramidal neurons. Correct modification
of the BAC was confirmed by Southern blotting (Figure 15B) and
subsequently injected into oocytes for implantation into pseudopregnant
females. Transgenic mice were identified by Southern blotting of genomic
DNA (Figure 15B).
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Figure 15. Expression of a Venus-GluR1 fusion protein in mouse
cortex. (A) Schematic of AMPA receptor subunit GluR1 N-terminally
fused to an affinity tag, Venus. The tag is present extracellularly.
(B) Southern blotting confirmed correct modification of an Otx1 BAC
with the Venus-GluR1 cDNA. Insertion of the transgene into the wildtype BAC (Wt) introduced an additional EcoR1 restriction site, resulting
in hybridization of the probe (red, in D) on a restriction band of smaller
size (Mod.). Genomic DNA from a wild-type (Wt) and transgenic (Tg)
mouse was analyzed by Southern blotting. The transgenic mouse shows
two bands, corresponding to the BAC transgene and the endogenous
Otx1 sequence. (C) Whole protein extract was collected from transgenic
(Tg) and wild-type (Wt) mouse cortex, separated by SDS page and
immunoblotted with an anti-GFP antibody. Extract from the transgenic
mouse shows a band corresponding in size to VGluR1. The lower nonspecific band is present at equivalent levels in tissue from both animals.
(D). Schematic of the Otx1 BAC transgene modified with Venus-GluR1.
The VGluR1 was inserted such that it disrupted the Otx1 ATG.
Approximately 75 Kb of upstream regulatory sequences is present in the
BAC. Scale bar = 2 Kb.
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We next tested the transgenic mice for expression of VGluR1 by
immunoblotting of cortical protein extract. An anti-GFP antibody detected a
band at 130 kDa, which corresponds to VGluR1, in protein extract from
transgenic, but not wild-type cortices (Figure 15C).

Expression of Venus-GluR1 in cortical and hippocampal neurons
We next sought to examine the expression pattern of VGluR1 in the mouse
cortex using immunohistochemistry with a goat anti-GFP antibody. Tissue
from several founder lines was examined, but the fusion protein was not
detectable by in the cerebral cortex.

However, one founder line (LH-

Otx1VGluR1-7) showed robust expression in the hippocampus, specifically
in regions CA3 and dentate gyrus (Figure 16A). Hippocampal expression
was specific to this particular founder line, suggesting that it is due to the
genomic position of the Otx1-VGluR1 BAC transgene. The fusion protein
was localized to dendrites (Figure 16A, far right), rather than the soma or
axon, corresponding to the correct localization of AMPA receptors. An
additional transgenic line, Otx1-GFP, which expresses soluble GFP under
the Otx1 BAC regulatory elements was examined in an identical way and
showed robust expression in cortical layer V neurons, but not in
hippocampus (Figure 16A, left and [146]).
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Figure 16. Expression of the Otx1-Venus-GluR1 transgene.
(A) Immunohistochemistry of fixed brain tissue from Otx1-GFP and
Otx1-VGluR1 mice using a goat anti-GFP antibody.

Robust GFP

expression was detectable in brain sections from Otx1-GFP mice in layer
V of the cerebral cortex.

Brain sections from Otx1-Venus-GluR1

(Otx1VGluR1) showed expression of the VGluR1 fusion protein in
hippocampus (CA3 and dentate gyrus).
detectable in the cerebral cortex.

VGluR1 expression was not

A higher magnification image of

staining in the hippocampus showed VGluR1 localized to dendrites, and
excluded from soma and axons. (B) A crude synaptosome preparation
was carried out on cortical and hippocampal tissue from Otx1-VGluR1
mice. Fractions were subject to SDS-PAGE and immunoblotted with
anti-GFP and other markers. Synaptic proteins were detectable in the
synaptic fraction, S2. S2 was solubilized with 1.0% Triton X-100 to
enrich for synaptic protein complexes (S3). This fraction was subject to
affinity purification using an anti-GFP antibody. VGluR1 was detected in
the immunopurified (IP) material from both cortex and hippocampus.
However, no additional synaptic proteins were co-immunopurified with
the VGluR1 fusion protein. Scale bars: left and center panels = 200um,
right panel = 50um.
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Figure 16. Expression of the Otx1-Venus-GluR1 transgene.

The additional hippocampal expression of the fusion protein in Otx1VGluR17 was potentially useful in that it might allow an in-subject
comparison between excitatory synapses from two distinct tissues, the
hippocampus and cerebral cortex, which could reveal site-specific GluR1
interacting proteins.
Biochemical purification of a crude synaptic fraction was carried out
as described [147] for both the hippocampus and cerebral cortex from the
Otx1-VGluR1 mice. An aliquot from each step of the purification was
separated by SDS-PAGE and immunoblotted with anti-GFP (Figure 16B).
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By immunoblotting, it was possible to detect VGluR1 only in the fractions
collected from the hippocampal tissue. Although immublotting of whole
protein cortical extract showed the presence of VGluR1, it was undetectable
after biochemical fractionation.
Next, the crude synaptosome fraction was solubilized with 1.0%
Triton X-100 in the case of cortex, and 0.1% Triton X-100 in the case of
hippocampus, to enrich for synaptic protein complexes, including the PSD.
This fraction, P3, was subject to co-immunopurification using a goat antiGFP antibody (Figure 16B). The co-immunopurified material was separated
by SDS-PAGE and immunoblotted with an anti-GFP antibody as well as
additional antibodies for detection of synaptic and non-synaptic markers.
While it was possible to detect the fusion protein in the IP from cortical
PSDs, it was much less abundant than that found in hippocampal PSDs. In
addition, we did not co-immunopurify any additional AMPA receptor
subunits, including the endogenous GluR1, nor GluR2. PSD95 was also
absent from the IP, as well as BIP and COX. The failure to detect additional
AMPA receptor subunits in this fraction can result from a failure of the
fusion protein to correctly incorporate into functional AMPA receptors, from
the failure of the receptor to traffic to the synapse, or from the method itself,
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in which we are attempting to affinity purify from a very crude and complex
sample of solubilized protein.
Because of the low expression of VGluR1 in cortex of Otx1-VGluR17
transgenic mice, we focused our attention on the hippocampus, which
robustly expressed VGluR1. In order to better enrich the starting material
for affinity purification we relied on gel filtration to separate large protein
complexes from smaller, intracellular ones. A percentage of each fraction
was separated by SDS-PAGE and analyzed by immunoblotting (Figure
17A). Several markers of excitatory synapses were enriched in the early
fractions, and are likely incorporated into large protein complexes. These
include Venus-GluR1 and the wild-type GluR1, as well as GluR2, PSD95
and GRIP. GABAARα1, a subunit of inhibitory neurotransmitter receptors,
was concentrated in later fractions, indicating a separation of excitatory and
inhibitory synaptic protein complexes under these conditions. In addition,
the endoplasmic reticulum (ER) marker, BIP, was largely excluded from the
early fractions and enriched in the later fractions that contain smaller,
trafficking protein complexes. Wild-type hippocampal tissue was processed
in the same way and immunoblotting of the fractions showed identical
distribution of the proteins mentioned above, with the exclusion of
VenusGluR1 (data not shown).
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Figure 17. Gel filtration of a solubilized synaptic fraction from Otx1VGluR1 followed by affinity purification. (A) A crude synaptic fraction
prepared from 10 hippocampi was solubilized with 0.1% Triton X-100
and subject to gel filtration.

1.0% in volume of every fraction was

separated by SDS-PAGE and assayed for the presence of excitatory
synapse markers (PSD95, GluR1, GluR2), inhibitory synapse markers
(GABAARα1), the endoplasmic reticulum marker, BIP and the
mitochondrial marker, COX. VGluR1 was detected using an anti-GFP
antibody. (B) The early fractions (6-10) were pooled and affinity-purified
using a mouse anti-GFP antibody (IP). 0.1% of the inputs and 25% of the
affinity-purified samples (IP) were assayed by Western blot using an antiGFP antibody and showed immunoprecipitation of VGluR1 from the
transgenic mouse. The same blot was probed for wild-type GluR1, GluR2
and PSD95, as well as the inhibitory neurotransmitter receptor subunit
GABAARα1.
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Next, we pooled the fractions enriched for excitatory synaptic proteins
and performed affinity purification with a mouse anti-GFP antibody (Figure
17B). The co-immunopurified material (IP) was separated by SDS-PAGE
and immunoblotted with a rabbit anti-GFP antibody, which showed the
presence of VGluR1 in the IP from Otx1-VGluR1 hippocampus.

The

endogenous GluR1 subunit was also present in the IP, as well as an
additional AMPA receptor subunit, GluR2, indicating that the VGluR1
fusion protein can assemble with wild-type AMPA receptor subunits.
Despite this, we did not detect any additional excitatory synaptic proteins,
such as PSD95, indicating that the VGluR1 containing AMPA receptors
may not incorporate properly into the synapse.

Generation of transgenic mice expressing Venus-GluR1 in various cortical
laminae.
Despite the failure of VGluR1 to successfully co-immunopurify
synaptic proteins when expressed under Otx1 regulatory elements, we were
not convinced that this fusion protein did not traffic to the synapse. It was
possible that the Otx1 driver was simply not sufficient for expression of this
fusion protein in cortex, or that the fusion protein was regulated differently
in the Otx1-positive layer V pyramidal neurons.
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In order to test this

hypothesis, and to facilitate a comparative study of GluR1-containing
excitatory synapses, we generated multiple lines of transgenic mice, each
expressing VGluR1 in a distinct cortical pyramidal cell population (Figure
18).
Each of the BAC drivers was selected for its specificity to pyramidal
neurons in a distinct layer of mouse cerebral cortex (Figure 8 and [146]).
The BAC modification was carried in a manner similar to Otx1-VGluR1,
except that resolution of the intervening shuttle vector sequences was not
necessary due to the improvement of the BAC modification technique. Four
BAC drivers, Drd4, Glt25d2, March4 and Ntsr1 were modified such that the
Venus-GluR1 fusion protein was expressed instead of the endogenous
protein (Figure 18A).
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Figure 18. Generation of multiple BAC transgenic lines expressing
Venus-GluR1. (A) Four BACs, Drd4, Glt25d2, March4 and Ntsr1, were
selected based on their expression in distinct cortical pyramidal cell
populations. Each was modified such that the Venus-GluR1 cDNA was
inserted at the level of the ATG. The amount of upstream regulatory
genomic sequences in each BAC is indicated. Insertion of the transgene
and shuttle vector (sv) sequences (not illustrated) introduced two
additional EcoR1 sites into the BAC. Scale bar = 20 kB. (B) Southern
blotting was used to confirm correct co-integration of the shuttle vectortransgene construct into the BAC. The probe (red box in A) corresponded
to those sequences used for homologous recombination and hybridizes to
two distinct restriction bands in the co-integrate (c). (C) Cortical protein
extract was collected from wild-type and transgenic mice and
immunoblotted for the presence of Venus-GluR1.

All four BAC

transgenic lines express the transgene, although the level of expression is
not more than that seen for Otx1-VGluR1. Cortical synaptic protein from
Glt25d2-VGluR1 was further analyzed by preparation of a solubilized
crude synaptic fraction (S3) subject to immunopurification with a mouse
anti-GFP antibody (C, right).

Venus-GluR1 was successfully

immunopurified from the PSD fraction.
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Figure 18. Generation of multiple BAC transgenic lines expressing
VGluR1.
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Correctly modified BACs were shown by Southern blotting to contain two
additional bands, due to the presence of EcoR1 restriction sites introduced
with the VGluR1-modified shuttle vector sequences (Figure 18B). Each
modified BAC was purified and injected into oocytes, which were surgically
implanted into pseudopregnant females. Successful incorporation of the
transgene was confirmed by dot blotting and PCR genotyping of genomic
DNA (data not shown).
To confirm expression of VGluR1 in the cortex of each BAC
transgenic line, we collected cortical protein extract and immunoblotted with
an anti-GFP antibody (Figure 18C, left panel). The fusion protein was
present in Glt25d2-VGluR1 cortical protein extract at a similar level to the
previously analyzed line, Otx1-VGluR1. Immunoblots of cortical extract
from Ntsr1-VGluR1 and March4-VGluR1 also detected VGluR1, but at
considerably lower levels.

Cortical extract from Drd4-VGluR1 did not

contain any detectable VGluR1 protein (data not shown). These results were
consistent across several founder lines for each BAC.

Furthermore,

immunoblotting detected the VGluR1 fusion protein in a solubilized, PSDenriched fraction (S3) from cortices of Glt25d2-VGluR1 mice (Figure 18C,
right panel). We were able to immunopurify VGluR1 from this fraction
using a mouse anti-GFP antibody, as shown by immunoblotting the IP
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material with a rabbit anti-GFP antibody. We attempted to further analyze
the expression of the transgene in these cortical expression lines by
immunohistochemistry of fixed brain tissue. However, as in the case of
Otx1-VGluR1 (Figure 16A), the fusion protein was undetectable in cortex
by immunohistochemistry for all of the lines (data not shown).
Because of the relatively high level of expression of VGluR1 under
the Glt25d2 BAC regulatory elements, this line was subject to further
biochemical analysis. A crude synaptic fraction was prepared from five
cortices and solubilized with 1.0% Triton X-100, followed by size exclusion
chromatography on a Sephacryl S1000 column.

A percentage of each

fraction collected was separated by SDS-PAGE and immunoblotted for
various proteins (Figure 19A). The early fractions, which contain large
protein complexes, were enriched in excitatory synaptic proteins (GluR1,
GluR2, PSD95, GRIP) and the mitochondrial marker, COX. The smaller,
likely intracellular protein complexes were enriched in later fractions and
contained makers of inhibitory synapses (GABAAR α1, GABAARβ2/3) and
the ER marker, BIP. Because of the low level of expression of VGluR1, it
was not possible to detect the fusion protein in the dilute fractions collected
after gel filtration. In order to confirm the presence of the fusion protein in
the various fractions, and to assess its distribution, we performed
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Figure 19.

Gel filtration of a solubilized synaptic fraction from

Glt25d2-VGluR1 transgenic mice followed by affinity purification.
(A) A crude synaptic fraction was prepared from 5 cortices, solubilized
with 1.0% Triton X-100 and subject to gel filtration. Each fraction was
assayed for the presence of excitatory synapse markers (PSD95, GluR1,
GluR2,

GRIP),

inhibitory

synapse

markers

(GABA(A)Rα1,

GABA(A)R β2/3), the endoplasmic reticulum marker, BIP and the
mitochondrial marker, COX. VGluR1 was immunopurified from each
fraction

using

a

mouse

anti-GFP

antibody

and

detected

via

immunoblotting with a rabbit anti-GFP antibody. (B) Fractions 6-10 were
pooled and affinity-purified using a mouse anti-GFP antibody and showed
immunoprecipitation of VGluR1 from the transgenic mouse (IP Tg) but
not wild-type (IP Wt). The same blot was probed for wild-type GluR1
and PSD95, as well as the inhibitory neurotransmitter receptor subunit
GABAARα1.
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immunopurification of each fraction using a mouse anti-GFP antibody
(Figure 19A, bottom). The immunopurified material from each fraction was
immunoblotted with an anti-GFP antibody, which detected VGluR1 in each
fraction, however, the distribution of the fusion receptor differed from that
of the endogenous GluR1 subunit. While both the fusion and wild-type
GluR1 subunits were enriched in the early fractions, which contain large
protein complexes, Venus-GluR1 was also enriched in the later fractions,
presumably in other intracellular compartments.

Tissue from wild-type

cortex was processed simultaneously and showed identical distribution of
wild-type proteins in the biochemical fractions as well as the absence of
VGluR1 (data not shown).
Next, we pooled the early fractions (6-9) from both Glt25d2-VGluR1
and wild-type cortices and performed affinity purification using a mouse
anti-GFP antibody (Figure 19B). VGluR1 was detected by immunoblotting
in the IP from transgenic but not wild-type cortex. The endogenous GluR1
was only slightly enriched in the IP from Glt25d2-VGluR1, compared to
wild-type. PSD95, the major excitatory synaptic scaffolding protein, and the
AMPA receptor subunit GluR2 (not shown) were absent from the IP, as was
the inhibitory neurotransmitter receptor subunit GABAARα1. As in the case
of Otx1-VGluR1, it appears that VGluR1 expressed under control of
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Glt25d2 regulatory elements does not traffic properly to excitatory synapses,
and perhaps does not form functional receptors.

Summary
Protein profiling in the mouse central nervous system necessitates that
one compare multiple synapse types. Using the BAC transgenic approach
we generated multiple transgenic lines each expressing a Venus-GluR1
fusion protein in a distinct pyramidal cell population. We intended to purify
GluR1-containing PSDs from each of these five pyramidal cell populations
and analyze the components by mass spectrometry for a comparative study.
Included in our study was Otx1-VGluR1, which would provide a useful
comparison to Otx1-VGABAARα1, a transgenic line that contains affinity
tagged inhibitory synapses.
The fusion protein showed correct topography in non-neuronal cells,
was successfully integrated into each BAC and was expressed by multiple
founder mice for each transgenic line generated.

Unfortunately, the

expression levels of this fusion protein in cortex were relatively low, and not
detectable by immunohistochemical methods. Nevertheless, we were able to
detect protein in cortical protein extract, demonstrating that the fusion
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protein was expressed under the control of the various BAC regulatory
sequences.
One Otx1-VGluR1 founder line expressed the fusion protein at robust
levels in CA3 and dentate gyrus of hippocampus. We further analyzed the
hippocampus from this line and the cortex of an additional line, Glt25d2VGluR1, for biochemical enrichment of VGluR1 in large protein complexes
that contain other markers of excitatory synapses. VGluR1 was present in a
crude synaptic fraction and in large protein complexes separated by gel
filtration, but at extremely low levels and in a distribution that differed from
wild-type GluR1. In addition, affinity purification of these pooled fractions
showed that VGluR1 did not co-immunopurify PSD95, an abundant
constituent of the excitatory postsynaptic specialization. Endogenous GluR1
was only minimally enriched in the IP from these transgenic lines. Together
these results suggest that Venus-GluR1 does not successfully incorporate
into synapses when expressed at physiological levels in both hippocampus
and cortex of adult mice.
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CHAPTER V. PROTEIN PROFILE OF INHIBITORY SYNAPSES IN
CEREBRAL CORTEX
Introduction
Synaptic activity in the central nervous system is defined as being
either excitatory or inhibitory, depending on the resulting change in
postsynaptic membrane potential.

The two types of input are

morphologically, biochemically and functionally distinct.

Fast synaptic

inhibition in the brain and spinal cord is mediated largely by ionotropic
GABA receptors, which are pentameric chloride ion channels [24]. GABAA
receptors also represent a major site of action of clinically relevant drugs,
such as benzodiazepines, barbiturates, ethanol, and general anesthetics. The
precise subunit composition of a given GABAA receptor determines its
expression pattern, subcellular localization and ligand affinities [2, 166-168].
The most common composition consists of two alpha, two beta and one
gamma subunit, with the α1 subunit expressed most abundantly in the
central nervous system [2, 3].
Excitatory synapses are easily enriched and purified biochemically
due to the presence of a detergent insoluble post-synaptic density (PSD),
thus the molecular architecture of these synapses is described in great detail
in the literature [25, 68, 169]. Inhibitory synapses, on the other hand, lack a
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large PSD and have not been purified or defined biochemically. Several
known protein constituents of inhibitory synapses were described in the
introduction.

A key component, gephyrin, is thought to be the major

scaffolding protein of this synapse. However, it has not been shown to bind
directly to GABA receptors, and is not necessary for clustering of all GABA
receptor subunits [28]. Because many of the proteins thought to colocalize
at inhibitory synapses are gephyrin-binding proteins, the list of inhibitory
synaptic elements is not conclusive.

Furthermore, many of these

interactions have been shown exclusively in vitro [170].
We have designed a novel in vivo method to biochemically purify and
analyze synaptic protein complexes and have applied this to GABAARα1
containing synapses in a specific class of layer V cortical pyramidal neurons.
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Results
Tagging inhibitory synapses in layer V cortical pyramidal neurons
In order to specifically purify inhibitory synapses from layer V cortical
neurons, we took advantage of the BAC transgenic approach for transgene
expression.

We selected the Otx1 BAC, which drives expression in a

specific population of layer V pyramidal neurons. The Otx1 BAC was
modified to express a fusion protein consisting of the GABAA receptor α1
subunit N-terminally fused to an affinity tag, Venus (Figure 20A). We first
transfected Venus-GABAARα1 (VGABAARα1) cDNA into HEK293 cells.
SDS-PAGE followed by immunoblotting with an anti-GFP antibody showed
that the protein was expressed and migrated at the expected size of 75 kDa
(data not shown). In addition, immunocytochemistry of non-permeabilized
HEK293 cells showed that the fusion protein was inserted into the plasma
membrane with the correct topographical organization, that is, with the
affinity tag, Venus, localized extracellularly (data not shown).
We then went on to modify the Otx1 BAC such that the Otx1 ATG
was disrupted by insertion of the Venus-GABAARα1 cDNA (Figure 20D).
Successful modification of the BAC was checked by Southern blot (Figure
20B). The insertion of the cDNA introduces an additional EcoR1 restriction
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Figure 20. Tagging inhibitory synapses in a population of cortical
layer V pyramidal neurons. (A) The GABAA receptor α1 subunit was
N-terminally fused to an affinity tag, Venus. The topography of the
receptor positions Venus extracellularly, to allow for efficient purification
of the synaptic complex. (B) Correct modification of the Otx1 BAC with
the Venus-GABAARα1 fusion construct was confirmed with Southern
blot (EcoRI digest, probe shown as red bar in (D)), before injection into
mouse oocytes. (C) Immunoblot analysis of cortical extract from both
wild-type (Wt) and transgenic (Tg) mice, using an anti-GFP antibody,
confirmed expression of Venus-GABAARα1. The fusion protein migrates
at the expected size of 75 kDa and is present only in extract from the
transgenic mouse. A nonspecific band is present in both extracts at
50 kDa. (D) Schematic diagram of the modification of the Otx1 BAC with
the Venus-GABAARα1 construct. Otx1 is expressed specifically in a
subpopulation of cortical layer V pyramidal neurons. Otx1 expression
was disrupted by introduction of the fusion construct at the level of the
Otx1 atg. The red bar indicates the probe used in (A). The arrow denotes
the likely start of regulatory sequences, based on the presence of upstream
coding region for an unrelated gene. Scale bar = 2 kB.
(E) Immunohistochemistry using an anti-GFP antibody confirmed the
expression of Venus-GABAARα1 in cortical layer V pyramidal neurons.
Brain sections from wild-type mice showed no detectable expression of
GFP, while the Otx1-Venus-GABAARα1 transgenic mice showed robust,
and specific layer V cortical expression.

A magnified view shows the

expression of the fusion protein in pyramidal cell soma (arrows) and
dendrites (arrowheads), in accordance with the known location of
inhibitory synaptic input.
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Figure 20. Tagging inhibitory synapses in a population of cortical layer
V pyramidal neurons.

site into the BAC, causing the modified BAC to hybridize the probe on a
restriction fragment of smaller size.
The correctly modified Otx1-Venus-GABAARα1 BAC was then
injected into oocytes, which were surgically implanted into pseudopregnant
females. Genomic DNA was purified from founder mice and analyzed by
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PCR (data not shown) and Southern blotting for successful insertion of the
transgene (Figure 20B, right). Southern blotting of genomic DNA from the
transgenic mouse shows hybridization at restriction bands of two sizes, the
larger band corresponds to wild-type Otx1, while the smaller band
corresponds to the Otx1-Venus-GABAARα1 transgene.
Expression of the transgene in vivo was confirmed by collecting
cortical protein extract.

Proteins were separated by SDS-PAGE and

immunoblotted with a rabbit anti-GFP antibody (Figure 20C). Extract from
transgenic mice contained a band corresponding to the VGABAARα1 fusion
protein, while wild-type extract lacked the fusion protein. A nonspecific
band (50 kDa) was present at equivalent levels in both extracts. Otx1VGABAARα1

transgenic

mice

were

further

analyzed

by

immunohistochemistry of fixed brain sections using a rabbit anti-GFP
antibody (Figure 20E). VGABAARα1 was detected specifically in layer V
pyramidal neurons in the brain sections from transgenic mice, while no
signal was detected in wild-type brain sections (Figure 20E, far left). The
fusion protein was detected in the cell body as well as the proximal and
distal dendrites, which corresponds to the known localization of inhibitory
synaptic inputs (Figure 20E, right).
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To further demonstrate the correct subcellular localization of
VGABAARα1, we performed immuno-electron microscopy on fixed brain
sections (Figure 21). We detected VGABAARα1 at the synaptic membrane
apposed to inhibitory terminals, which were visualized by immunostaining
with an anti-GAD65/67 antibody. These synapses were found on the cell
body of layer V pyramidal neurons (Figure 21A, C) and dendrites (Figure
21B, D). The inhibitory terminals were identified by the presence of GAD,
the shape and size of the synaptic vesicles, and the lack of PSD (symmetric
synapse). VGABAARα1 was not present at excitatory terminals except in
cases where a single spine head was innervated by both excitatory and
inhibitory terminals (Figure 21D).

VGABAARα1 was also found

prominently in subcellular compartments (Figure 21A, inset), most likely as
part of trafficking complexes.
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Figure

21.

GABAARα1

Immuno-electron
localizes

to

microscopy

inhibitory

confirms

synapses.

Venus-

VGABAARα1

immunolabeling is revealed by the SIG procedure in figures (A), (B), and
(D) and by the DAB procedure in figure (C). Inhibitory terminals are
immunoreactive for GAD65/67, which is revealed with the DAB
procedure.

(A) A GAD immunoreactive terminal, indicated by an

asterisk, contacts the soma of a layer V pyramidal neuron and colocalizes
with Venus-GABAARα1, indicated by an arrow.

VGABAARα1

immunoreactivity is also seen intracellularly (arrowhead and inset).
Asymmetric synapses are immunonegative for both GAD and
VGABAARα1 (dashed arrows). (B) A GAD immunoreactive terminal
(asterisk) colocalizes with Venus-GABAARα1 (arrow) on the dendritic
shaft.

(C) A layer V pyramidal cell expresses VGABAARα1

intracellularly (arrowhead) and on the plasma membrane. The expression
colocalizes with a GAD immunoreactive terminal (asterisk). (D) A GAD
immunoreactive terminal (asterisk) makes a symmetric synapse onto a
spine head that is immunopositive for VGABAARα1 (arrow). The same
spine also forms an asymmetric synapse (dashed arrow) that is
immunonegative for GAD. An additional spine (upper left corner, dashed
arrow) makes only an asymmetric synapse and is immunonegative for
VGABAARα1. Scale bars: A-C = 500µm; D = 100 µm. Cy: cytoplasm.
Nu : nucleus. Sh: spine head. De: dendrite.
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Figure 21. Immuno-electron microscopy confirms Venus-GABAARα1
localizes to inhibitory synapses.
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Biochemical purification of inhibitory synaptic protein complexes
After confirming the correct subcellular localization of the VenusGABAARα1 fusion protein we went on to biochemically purify the tagged
synapses. Several methods for purification of GABA receptors have relied
on detergent solubilization of a synaptic fraction, most frequently using the
detergent sodium deoxycholate [171]. While these methods are useful for
purifying intact receptors, we were not able to purify synaptic protein
complexes in this way (data not shown).

Instead, we made several

modifications to the novel method we devised to purify tagged parallel fiberPurkinje cell synapses of the cerebellum (Figure12A). Optimization of this
method for enrichment of VGABAARα1 tagged synapses proved successful.
Cortices from five mice were homogenized and a crude synaptosome
fraction was obtained by differential centrifugation. Solubilization of this
fraction in a final concentration of 0.1% Triton X-100 proved sufficient to
purify intact inhibitory synaptic complexes.

Sodium deoxycholate and

CHAPS were also tested for their ability to solubilize Venus-GABAARα1.
Sodium deoxycholate was efficient in solubilizing the GABA receptor but it
disrupted receptor-protein interactions, while CHAPS was inefficient (data
not shown).
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After solubilization, the S3 fraction was separated by size-exclusion
chromatography using the gel filtration resin, Sephacryl S1000. In this way,
it was possible to separate large protein complexes containing VGABAARα1
from those that were smaller, and likely corresponding to intracellular
protein complexes. Protein from each fraction was separated by SDS-PAGE
and subject to immunoblotting for known markers of inhibitory and
excitatory synapses, as well as the endoplasmic reticulum (ER) marker, BIP,
and the mitochondrial marker, COX (Figure 22A). The early fractions (610) were enriched for synaptic and mitochondrial proteins, while the ER
marker was selectively enriched in the later fractions (11-14), further
validating their distinct subcellular localization. VGABAARα1 was detected
using a rabbit anti-GFP antibody and segregated in the gel filtration fractions
similarly to wild-type GABAARα1. The GABA receptor subunits α1, β2/3
and γ2, as well as the scaffolding protein, gephyrin, were distributed
throughout the fractions, suggesting their incorporation in protein complexes
of both large and small size.

GABAARα2, on the other hand, showed

selective enrichment in the earlier fractions, more closely resembling the
excitatory synaptic components, such as PSD95 and GluR2. The difference
in fractionation of the GABAARα1 and -α2 subunits correlates to known
differences in their immunocytochemical localization and clustering [97].
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Figure 22. Enrichment of inhibitory synaptic fractions followed by
affinity purification of VGABAARa1 tagged synapses. (A) We
prepared a crude synaptosome fraction, P2, which was solubilized in 0.1%
Triton X-100 and centrifuged to prepare a fraction, S3, enriched in
inhibitory synaptic complexes. The extract was then separated on a
Sephacryl S1000 gel filtration column. 0.1% in volume of every fraction
was analyzed by immunoblotting for the presence of inhibitory synapse
markers

(GABA(A)Rα1,

GABA(A)Rα2,

GABA(A)Rβ2/3,

GABA(A)R γ2, gephyrin), excitatory synapse markers (PSD95, GluR2),
the endoplasmic reticulum marker, BIP and the mitochondrial marker,
COX. VGABAARa1 was detected using an anti-GFP antibody. The red
rectangle outlines the “synaptic” fractions enriched for synaptic markers
and pooled for subsequent affinity-purification of VGABAARa1 tagged
synapses. Protein dosage was performed on every fraction collected. The
void volume was determined by the elution of Dextran blue sulfate.
(B) Synaptic fractions (Input 6-10) from Otx1-VGABAARa1 mice were
pooled and affinity-purified using a mouse anti-GFP antibody (IP
VGABAARa1).

In parallel, control purifications were performed on

preparations from Otx1-GFP transgenic mice (IP GFP). 1.0% of the
inputs and 10% of the affinity-purified samples (IP) were assayed by
Western

blot

using

an

anti-GFP

antibody

and

showed

immunoprecipitation of both VGluRδ2 and GFP, respectively. The same
blot was probed for different synaptic markers and the mitochondrial
protein COX, showing specific co-immunopurification of inhibitory
synaptic markers.
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Figure 22. Enrichment of inhibitory synaptic fractions followed by
affinity purification of VGABAARa1 tagged synapses.

The same purification scheme was used to enrich for inhibitory synaptic
proteins from an Otx1-GFP transgenic mouse, which expresses soluble GFP
in the equivalent population of pyramidal neurons, and serves as a control
for affinity purification.

The distribution of proteins was identical in

fractions purified from the Otx1-GFP cortices (not shown).
Next, synaptic fractions 6-10 from Otx1-GFP or Otx1-VGABAARα1
were pooled and subject to affinity purification using a mouse monoclonal
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anti-GFP antibody. The affinity-purified proteins were separated by SDSPAGE and immunoblotted for both synaptic and nonsynaptic proteins
(Figure 22B).

We detected either GFP or VGABAARα1 in the

immunopurified (IP) material using an anti-GFP antibody. The wild-type
GABAA receptors α1, β2/3 and γ2 were detected in the IP from the Otx1VGABAARα1 mouse, confirming that the fusion protein incorporates
correctly with the endogenous GABAAR subunits. Alternatively, GABAA
receptor α2 was absent from the IP lane. Excitatory synaptic components,
such as PSD95, GluR1 and GluR2 were also absent from the IP, as well as
the ER marker, BIP, and the mitochondrial marker, COX. Material from the
Otx1-GFP control mouse lacked any co-immunopurified proteins,
confirming the specificity of our affinity purification technique. Standard
amounts of soluble GFP were also run on the gel, to allow approximation of
the quantity of fusion protein. This was useful in determining the amount of
protein to pool for analysis by mass spectrometry.

Mass spectrometry of cortical inhibitory synapses
Affinity purified synaptic material was pooled from 25 cortices from
either Otx1-Venus-GABAARα1 or Otx1-GFP and analyzed by mass
spectrometry. Proteins were alkylated and denatured, separated by SDS130

PAGE and stained with zinc. Excised bands were digested with trypsin and
the resulting peptides subject to liquid chromatography-tandem mass
spectrometry (LC-MS/MS). Using this method we have so far generated a
list of 12 proteins found specifically in the material immunopurified via
VGABAARα1, and absent from the material purified via GFP (Table 5).
Mass spectrometry identified several wild-type GABAAR subunits,
including α1, α2, α3, β1, β2, β3 and γ2, all of which are expressed in
inhibitory cortical pyramidal cells.

It is noteworthy that GABAARα2

subunit was present, as this subunit was not detectable by immunoblotting of
the same material. This is likely due to the difference in abundance of the
immunopurified material in the two types of analysis. Absent from our coIP were several non-cortical GABAAR subunits, including α6, which is
exclusively expressed in cerebellar granule cells and the cochlea, and the γ1
subunit, which is enriched in the amygdala, pallidal areas, the substantia
nigra and the inferior olive [3].
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Table 5. Proteins uniquely immunopurified via Venus-GABAARα1
Protein name (a)
Isolated
GABA(A) receptor subunit alpha-1
proteins
GABA(A) receptor subunit alpha-2
(mus
GABA(A) receptor subunit alpha-3
musculus) GABA(A) receptor subunit beta-2
GABA(A) receptor subunit beta-1
GABA(A) receptor subunit beta-3
GABA(A) receptor subunit gamma-2
Synaptic vesicle glycoprotein 2B
Gephyrin
Neuroligin-2
Glutamate receptor ionotropic, AMPA 2
Homer protein homolog 1 (VASP/Ena-related gene)
Likely
Alpha-actinin-1
contaminants Alpha-actinin-2

sequence
unique
ensemble # (b) MW(kDa) log(e)+ (c) coverage(%) (d) peptide # (e) peptide # (f)
00000020707
51.7
-107.6
29.4
17
8
000000572
51.1
-61.9
19.5
8
3
00000062638
55.4
-36.3
9.5
5
2
00000007797
54.6
-74.1
27.4
10
4
00000031122
54.1
-46.9
19.2
7
2
00000038051
54.1
-46.7
22.2
9
2
00000063812
55.1
-13.9
7.8
3
00000065495
77.4
-6.2
3.2
2
00000054064
80.7
-20.4
6.1
4
00000053097
90.9
-143.3
21
16
00000074787
98.7
-18.9
5
5
00000079026
41.6
-19.9
10
4
00000021554
103
-44.5
8
6
00000067708
103.8
-7.8
2.6
2

Table 5. Proteins uniquely immunopurified via Venus-GABAARα1
were determined by subtracting proteins immunoisolated via GFP.
(a) Proteins were identified by the GPM protein sequence database search
program using data from LC-MS/MS experiments. (b) Ensemble # is the
protein accession number in Ensemble Mouse database. (c) Log(e) is the
base-10 log of the expectation that an assignment is stochastic.
(d) Sequence coverage shows the percentage of protein sequence covered
by the identified peptides. (e) Peptide # shows the number of identified
peptides. (f) Unique peptide # shows the number of peptide matches that
are unique to the homologue, when more than one homologues are
reported.

132

In addition to GABAA receptor subunits, we found two additional inhibitory
synaptic proteins in the immunopurified material, gephyrin and neuroligin-2
(NL-2). Gephyrin, a microtubule binding protein, is a known component of
inhibitory synapses [108, 172] and may be important for clustering of these
receptors [107].

Neuroligin-2 is a cell adhesion molecule with known

specificity for inhibitory synapses [138], which likely plays a role in
synaptogenesis and maintenance of these contacts.

The presence of

gephyrin and NL-2 in the IP was confirmed by immunoblotting (Figure 23).

Figure 23. Immunoblot analysis confirms the presence of gephyrin
and neuroligin-2 in immunopurified material.

Inhibitory synaptic

complexes were biochemically enriched from 5 cortices and affinity
purified using a monoclonal mouse anti-GFP antibody against soluble
GFP (IP GFP) or Venus-GABAARα1 (IP VG(A)Rα1). The total amount
of IP was separated by SDS-PAGE and analyzed by immunoblotting for
gephyrin and neuroligin-2 (NL-2).
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Excitatory synaptic components are almost entirely excluded from the IP,
with the exception of the AMPA receptor subunit, GluR2. The presence of
GluR2 was surprising given the absence of GluR2 on immunoblots, but
might be relevant as it appeared in the absence of additional excitatory
proteins, including additional AMPA receptor subunits and PSD95.
Two potentially novel members of inhibitory synapses were identified
by mass spectrometry, Homer protein homolog 1 (Homer1) and Synaptic
vesicle glycoprotein 2B (SV2B). Homer is known to cluster components of
the excitatory postsynaptic density [75], and may play a similar role at
inhibitory synapses. SV2B is located presynaptically and, together with
SNAP-25 and synaptotagmin, functions in neurotransmitter release [173].
Further work will be necessary to clarify whether SV2B is a contaminant or
is localized postsynaptically at cortical inhibitory synapses.

Summary.
We have successfully generated transgenic mice that express a VenusGABAARα1 fusion protein in layer V cortical pyramidal neurons. Light and
electron microscopy confirmed the presence of the tagged receptor at
inhibitory synapses in the targeted cell type. A novel approach to the
biochemical enrichment of inhibitory synaptic protein complexes followed
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by affinity purification via the tagged receptor, proved efficient in isolating
the inhibitory synaptic protein complex. Mass spectrometry of this complex
revealed twelve proteins, including several GABAAR subunits expressed in
cortical pyramidal neurons.

We also identified two specific inhibitory

synaptic clustering proteins, gephyrin and neuroligin-2, thus demonstrating
the efficacy of our method for the in vivo biochemical purification of
inhibitory synaptic complexes.
Mass spectrometry also identified several components whose
functions are not readily apparent.

The presence of excitatory AMPA

receptor GluR2 subunit as well as Homer protein homolog 1, coupled with
the absence of additional AMPA receptor subunits or the major excitatory
scaffolding protein, PSD95, suggests a novel function or localization of
these synaptic proteins.

Further analysis of this complex, including

additional affinity purification experiments, will be required to determine the
specificity of these proteins to inhibitory synapses in mouse cerebral cortex.
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DISCUSSION
Activity at the synapse, a discrete site of contact between the pre- and postsynaptic neurons, is the basis for neurotransmission in the central nervous
system.

Synapses are complex and dynamic structures, composed of a

multitude of proteins, such as neurotransmitter receptors, scaffolding
proteins, and signaling molecules. Given that an individual neuron receives
thousands of synaptic inputs, there likely exists a molecular mechanism for
defining and maintaining unique synapse types. To determine the protein
specification for individual synapses it is necessary to purify and analyze the
protein content of only a single class of synapse. A comparative analysis of
multiple synapse types could lead to valuable insights into the molecular
mechanisms of synapse specification. Such a comprehensive approach is
possible due to the availability of hundreds of BAC vectors for neuronal
cell-type specific expression of a transgene (www.gensat.org). We have
taken advantage of this approach to target individual cell types for
expression of a synaptic affinity tag, which was then used to purify synaptic
protein complexes. Mass spectrometric analysis was used to generate a
protein profile of each purified synapse type and to identify novel and
functionally relevant synaptic proteins.
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We first targeted the parallel fiber to Purkinje cell (PF/PC) excitatory
synapse of the cerebellum for purification and mass spectrometry analysis.
The PF/PC synapse is unique in that it contains the orphan receptor, GluRδ2,
which is genetically defined as being between NMDA and non-NMDA
receptor types. Although the precise function of GluRδ2 is not completely
understood, is required for correct motor development and function, and has
also been implicated in several neurological diseases [162].

It is also

necessary for long-term depression in the cerebellum, and motor learning
dependant on this structure [80]. A second excitatory input to the Purkinje
cell is from climbing fibers (CF/PC), but these synapses do not contain
GluRδ2 [65]. Proteomic analysis is likely to provide insight into the unique
molecular and functional properties of the PF/PC synapse.
To analyze only the PF/PC synapse, we targeted expression of a
Venus-GluRδ2 fusion protein to Purkinje cells of the cerebellum. This
fusion protein enabled affinity purification of the PF/PC synaptic protein
complex using an anti-GFP antibody to recognize Venus.

A major

advantage of employing a synaptic affinity tag is that it allowed comparison
of the immunopurified proteins to those contaminants immunopurified via
soluble GFP expressed in the same cell type. In order to maximize recovery
of synaptic proteins for analysis by mass spectrometry, we employed a novel
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method of PSD purification that relied on gel filtration of a solubilized crude
synaptic fraction.

Gel filtration resulted in a a pool of large protein

complexes, enriched in excitatory synaptic proteins, including VenusGluRδ2, relative to trafficking and inhibitory synaptic proteins. Affinity
purification with an anti-GFP antibody was successful in purifying a large
protein complex that contained GluRδ2 and other markers of excitatory
synapses, such as GluR2 and PSD95, while components of inhibitory
synapses and ER were absent.
Mass spectrometric analysis of this complex identified 65 proteins,
which were organized into 11 functional categories.

Most of these

categories have previously been included in descriptions of the postsynaptic
specialization [174], but one category, “phospholipid metabolism and
signaling” contained several members newly associated with the PF/PC
synapse. This group included eight proteins that can regulate or be regulated
by phospholipid metabolism (Iptr1, synaptojanin 1 and 2, phospholipase B,
ABCA12, MRCKγ) or contain phospholipid binding domains (Plekha7,
annexin A6, MRCKγ). This suggests that phospholipid regulation is a major
feature of the PF/PC synapse, in accordance with the major role of the
metabotropic glutamate receptor 1 (mGluR1) in regulating the physiology of
the PF/PC synapse [67].

mGluR1 exerts its action by inducing
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phosphatidylinositol-4,5-P2 (PIP2) hydrolysis [175, 176].

Two of the

proteins we identified, MRCKγ and Itpr1, respond to the metabolites of
PIP2 hydrolysis (DAG and IP3, respectively) and may be key components of
the molecular pathway by which mGluR1 functions at this synapse.
Phosholipid metabolism has been strongly implicated in presynaptic
functions, such as vesicle recycling [177], and our results show that it also
likely plays a role in postsynaptic regulation of the synapse. In particular,
two proteins we identified at PF/PC synapses, synaptojanin-1 and -2, are
PIP2-metabolizing enzymes that are found both pre- and post-synaptically
[174].

Another interesting member of this category, MRCKγ, has not

previously been shown at PF/PC synapses and is known to modulate actin
cytoskeleton and cell morphology [178].

This is interesting since

deficiencies in spine length and spine morphology of Purkinje cells may play
a role in neurodevelopmental diseases such as mental retardation and
Angelman syndrome [145, 159].
The diversity of proteins present at the PF/PC synapse demonstrates
the complexity of the PSD and suggests the possibility of a “synaptic code”
to define individual synapse types. Proteins that contain classical adhesion
domains are commonly found at synapses and targeting of particular
adhesion molecules could specify synapse types. For example, our study
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identified Neph1 and the receptor tyrosine phophatase, RPTPmu. Given the
known role of the C. elegans Neph1 homolog, SYG1, in specifying synapses
in vivo, it is possible that Neph1 may play a role in specifying the PF/PC
synapse as distinct from the CF/PC synapse. Receptor tyrosine phosphatases
play important roles in axon guidance, and have also been shown to control
synapse formation [179].
The majority of proteins identified in this study are specifically
expressed in Purkinje cells.

This conforms with previous studies of

expression analysis of proteins identified in bulk synapse preparations,
which show that receptors and other upstream signaling molecules have a
highly variable expression pattern in the vertebrate brain [180].
Furthermore, the diversity of excitatory inputs within the Purkinje cells may
suggest that quite distinct sets of proteins are necessary for specifying an
individual class of synapse.
Our initial approach to the study of such specificity employed the
expression of Venus-GluRδ2 fusion protein in the Purkinje cell, which is
localized specifically to the PF/PC synapse. In order to identify synaptic
proteins enriched at other excitatory inputs to Purkinje cells, we sought to
express a Venus-GluR2 fusion protein under the same BAC regulatory
control elements.

Since GluR2 is present at both PF/PC and CF/PC
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synapses [65], a subtraction method could be used to define a class of
proteins differentially expressed at each synapse type. Although it was
possible to express Venus-GluR2 in HEK293T cells (not shown) this fusion
protein was not expressed in vivo in the cerebellum (Pcp2-VGluR2) or in the
cortex (Otx1-VGluR2).
An instructive comparison to identify regulators of synaptic
specificity is between excitatory synapses in distinct brain regions and/or
cell types. We took advantage of the available BAC vectors for cortical
pyramidal cell expression to localize a Venus-GluR1 fusion protein to
excitatory synapses in distinct cortical cell types. Although VGluR1 was
expressed with correct topography in HEK293 cells, only low levels were
detectable in the cortex in vivo under control of several BAC vector
sequences (Otx1, March4, Ntsr1, Drd4, Glt25d2).

One transgenic line,

Otx1-VGluR17 expressed VGluR1 in CA3 and DG of hippocampus due to a
positional effect of transgene insertion. VGluR1 was highly expressed and
appeared by immunofluorescence to localize to dendrites. However, affinity
purification of VGluR1 from hippocampus and cortex of Otx1-VGluR17,
and from cortex of an additional line (Glt25d2-VGluR1) showed that this
fusion protein did not likely traffic to synapses.
Our findings that Venus-GluR2 and Venus-GluR1 are not correctly
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localized to excitatory synapses in vivo are contrast with a number of studies
that utilize these fusion proteins to examine AMPA receptor function [84,
86-88, 181]. GFP-GluR1 fusion protein expressed in vitro mainly forms
homomeric receptors that are distinguished electrophysiologically by
alterations in their rectification properties [86, 87].

In one study, GPF

tagged GluR2 was expressed in cultured hippocampal neurons, efficiently
inserted into the synapse and was shown to interact with GRIP and NSF,
known regulators of AMPA receptor trafficking [181]. In another study,
GFP-GluR1 was introduced into neurons with the Sindbis virus expression
system to levels three times that of endogenous GluR1 and trafficked
efficiently to synapses [86].

In both experiments, recombinant GluR1

subunits were distributed similarly to the endogenous GluR1 subunit and
delivered to the synapse.
There are several potential explanations for the differences in
expression of tagged glutamate receptors in our BAC transgenic animals
compared to those published in the literature. First, there are likely greater
regulatory constraints on glutamate receptor expression and trafficking in the
intact brain than in dissociated neurons or organotypic slice cultures. These
differences may manifest by cell type, as exemplified by the higher level of
expression of VGluR1 in hippocampus than in cortex, and the fact that most
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studies of these recombinant receptors were carried out in dissociated
hippocampal neurons or hippocampal slice cultures.

Tissue specific

regulation of AMPA receptor trafficking is supported by the expression of
distinct transmembrane AMPA receptor regulatory protein (TARP) isoforms
in hippocampus and cortex, which interact with AMPA receptors at the postsynaptic density and are required for their surface expression [182]. Second,
most expression systems result in levels of AMPA receptor fusion protein
those are much higher than endogenous levels. If only a small percentage of
GFP-GluR1 is properly assembled into synaptic protein complexes, it would
be possible to detect this protein at synapses only when expressed at
extremely high levels. Third, homomeric GFP-GluR1 receptors may not be
efficiently trafficked to the synapse in vivo at physiological levels of
expression.
Finally, the fact that Venus-GluR2 was not expressed at all in our
transgenic mice points to differences in the regulation and trafficking of the
various AMPA receptor subunits [183, 184]. AMPARs assembled as GluR2
homomers or GluR2/GluR3 heteromers cycle in and out of the synaptic
membrane in a constitutive manner, which does not require synaptic activity
[185, 186]. This constitutive trafficking requires GluR2-specific interactions
with NSF [187].

In contrast, AMPARs containing the GluR1 subunit
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translocate into spines and are inserted into synapses in response to NMDAreceptor activation during LTP [84].

The constitutive nature of GluR2

trafficking may indicate differences in regulation of assembly and insertion
of this subunit and preclude the expression of a Venus-tagged GluR2 subunit
at physiological levels in vivo.
Because we could not co-immunopurify any excitatory synaptic
proteins via Venus-GluR1 or Venus-GluR2, it was not possible to profile
additional excitatory synapses.

Improvements in the design of affinity

tagged AMPA receptor subunits may facilitate their proper insertion into
synapses and enable future studies.
In addition to excitatory synapses, we undertook a study of inhibitory
synaptic protein complexes. Because inhibitory synapses lack a detergent
insoluble PSD, they have not been biochemically purified with classical
methods. Our alternative method relied on size exclusion chromatography
rather than density centrifugation to enrich for large protein complexes.
This approach enabled the purification of a complex of inhibitory synaptic
proteins.

Using the BAC transgenic approach, we expressed a Venus-

GABAAα1 subunit in a subpopulations of pyramidal neurons of mouse
cerebral cortex and showed that this receptor was similar to the endogenous
GABAAα1 subunit in the various purification steps.
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Interestingly, gel

filtration revealed differences in the subcellular distribution of GABAAα1
and α2 subunits. The α2 subunit was concentrated in the early fractions,
which contained large protein complexes, and its distribution resembled
markers of insoluble excitatory PSDs. By contrast, the α1 subunit was
distributed throughout the fractions, in both large and small protein
complexes.

These observations correlate with published differences in

GABAA receptor subunit distribution in neurons. For example, hippocampal
pyramidal neurons cluster receptors containing α2 subunits at synapses on
the axon initial segment and dendrites, whereas receptors containing α1
subunits are more uniformly expressed [10, 96].

In addition, a diffuse

GABAA receptor subunit immunoreactivity can be seen throughout the brain
in addition to clusters, suggesting the presence of a sizable pool of
extrasynaptic receptors [95, 108], as shown by postembedding immunoelectron microscopy [96]. We also saw a large population of extrasynaptic
Venus-GABAAα1 subunit by electron microscopy, and saw both the tagged
and wild-type α1 subunits distributed across both large- and small-proteincomplex fractions during gel filtration. The distribution of GABAA receptor
subunits may be indicative of differences in their subcellular localization or
unique trafficking properties. A better understanding of such differences
could be gained by subunit-specific proteomic analysis of GABAA receptor
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interacting proteins.
We used affinity purification to explore the proteins present at VenusGABAAα1 tagged inhibitory synapses. By pooling the purified material
from an equivalent of twenty-five cortices, we were able to identify twelve
proteins specifically immunopurified with Venus-GABAAα1. This list is
preliminary, as we have not yet replicated the mass spectrometry analysis.
Of these twelve proteins, most were additional GABAA receptor subunits,
including α1, α2, α3, β1, β2, β3, and γ2, all of which are expressed in
inhibitory cortical pyramidal cells. This result indicates that the tagged α1
receptor assembles properly into mature GABAA receptors. The α2 subunit
is likely present in this complex at lower levels than wild-type α1, β2, β3
and γ2, as it was not initially identified by immunoblotting of a small
percentage of the purified material. As described above, the α1 and α2
subunits are thought to segregate into distinct receptor pools in vivo.
Perhaps they only colocalize in a fraction of synapses, and this interaction is
detectable only by the very sensitive methods of mass spectrometry for
detection of proteins in a complex sample.
In addition to the various receptor subunits, mass spectrometry
positively identified gephyrin, a multidomain protein that likely provides a
scaffold for postsynaptic proteins and an anchor to the cytoskeleton [28]. A
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recent study has identified a 10-amino-acid sequence within the major
intracellular domain of the α2 subunit that regulates the accumulation of
GABAA receptors at postsynaptic specializations, in a process dependent on
gephyrin [107]. Studies of the retina have shown that GABAA receptors
containing the α1 subunit were not colocalized with gephyrin, suggesting
that gephyrin was associated only with certain receptor subtypes [188].
However, recent results indicate that in brain gephyrin does in fact
colocalize with GABAA receptor subunits α1, α2, and α3, as well as the γ2
subunit [98]. Our results provide further evidence that gephyrin is indeed
present at GABAAα1 containing synapses.
The precise function and localization of gephyrin in clustering of
GABAA receptors remains elusive, as many studies have provided
contrasting results.

Whereas removal of gephyrin by gene targeting or

mRNA expression interference strongly affects GABAA receptor clustering
[189], some GABAA receptor clusters can still form in neurons lacking
gephyrin [110]. Furthermore, the subsynaptic localization of gephyrin in
GABAergic synapses depends on GABAA receptor clustering. That is, when
GABAA receptor postsynaptic clusters are disrupted by targeted deletion of
the gene encoding the γ2 subunit, gephyrin clusters disappear and the
receptors disperse in the cell membrane [190, 191]. The distribution of
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gephyrin in our gel filtration fractions to both large and small protein
complexes may underlie its divergent functions. Inconsistencies in the data
on the role of gephyrin at inhibitory synapses suggest the presence of
additional clustering and scaffolding molecules that regulate inhibitory
synaptic structure.
One potential regulatory protein is neuroligin-2, a cell adhesion
molecule involved in synapse formation [122, 192, 193] and localized
specifically to inhibitory synapses in vivo [138]. Studies have shown that
neuroligins are capable of inducing both excitatory and inhibitory
presynaptic contact formation, and that the precise synapse formed depends
on interactions of the appropriate neuroligin with scaffolding molecules,
such as neurexin1-β and PSD95 [194]. For example, enhanced expression
of PSD-95 induces clustering of NL-2 and NL-3 and shifts endogenous NL2 from inhibitory to excitatory synapses [195]. These findings provided
evidence that assembly of specific postsynaptic elements can regulate a
balance between excitatory and inhibitory synapses. Thus, abnormalities in
the expression of and/or interactions between these molecules may result in
aberrant synapse formation and a change in the ratio of excitatory to
inhibitory inputs.

An upset in the balance of excitatory and inhibitory

synapses is thought to underlie complex psychiatric disorders [196-198].
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The identification by mass spectrometry of NL-2, and the absence of NL-1,
demonstrates the specificity and efficacy of our approach to purifying
inhibitory synaptic protein complexes.
In addition to specific markers of inhibitory synapses, mass
spectrometry of Venus-GABAA α1 tagged protein complexes identified two
proteins that are typically found at excitatory receptors, AMPA receptor
subunit GluR2 and Homer protein homolog 1. It is noteworthy that the
GluR2 subunit alone was localized to our tagged inhibitory synapses, since it
is typically found as part of heteromeric receptors that contain either GluR1
or GluR3 [199]. The GluR2 subunit of AMPA receptors interacts with NSF
and this interaction has been shown to cause differences in intracellular
sorting and trafficking of GluR2 compared to the other AMPA receptor
subunits [184]. GABARAP, a GABAA receptor binding protein, also binds
NSF and is involved in trafficking of receptors to the synapse [170, 200].
Further analysis will be required to determine if AMPA receptor GluR2
subunits are in fact localized to inhibitory synapses, and if this is mediated
by GABARAP via their common interaction with NSF.
Homer protein homolog 1 (Homer1) is a member of the Homer family
of adaptor proteins, which are predominantly localized to the PSD in
mammalian neurons. Each Homer protein has several variants, which are

149

classified primarily into the long and short forms. The long Homer forms,
which include Homer1, are constitutively expressed and consist of two
major domains: the amino-terminal target-binding domain, which includes
an Enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) homology 1
(EVH1) domain, and the carboxy-terminal self-assembly domain containing
a coiled-coil structure and leucine-zipper motif [75]. The EVH1 domain is
homologous to that of mENA/VASP, a microfilament binding protein
known to be involved in the structural organization of inhibitory synapses
[111, 201]. Perhaps Homer1 also plays a role in the structural integrity of
these synapses via its interaction with additional adapter molecules, although
immunohistochemical analysis of Homer1 localization in cortical pyramidal
neurons is necessary to confirm its presence at inhibitory synapses.
Evidence for the presence of postsynaptic scaffolding proteins common to
both inhibitory and excitatory receptors is supported by the identification of
an isoform of GRIP1 that colocalizes with GABA receptor in cultured
hippocampal neurons [112]. It is possible that we have identified a unique
isoform of Homer in inhibitory synaptic protein complexes.
Our ability to tag and purify individual synapse types was facilitated by
the use of BAC transgenesis for expression of synaptic tags in a multitude of
cell types. We have shown here that it is indeed possible to analyze an
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individual class of synapse and generate a list of specific and functionally
interesting synaptic proteins. The value of such an approach lies in the
ability to compare multiple synapse types across various brain regions.
Already we can observe a striking difference in the molecular complexity of
excitatory and inhibitory synaptic protein complexes. This difference is
expected, as the simpler, symmetric structure of inhibitory synapses suggests
that they contain vastly fewer molecules. In the case of both excitatory and
inhibitory synapses we have identified novel potential synaptic components
whose functional relevance will be assayed in future experiments.
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